Thrombin	B-protein
generation	O
by	O
apoptotic	B-cell_type
vascular	I-cell_type
smooth	I-cell_type
muscle	I-cell_type
cells	I-cell_type
.	O

Thrombin	B-protein
activation	O
requires	O
assembly	O
of	O
a	O
prothrombinase	B-protein
complex	I-protein
of	O
activated	O
coagulation	B-protein
factors	I-protein
on	O
an	O
anionic	O
phospholipid	O
surface	O
,	O
classically	O
provided	O
by	O
activated	B-cell_type
platelets	I-cell_type
.	O

We	O
have	O
previously	O
shown	O
that	O
anionic	O
phosphatidylserine	O
is	O
exposed	O
by	O
rat	B-cell_type
vascular	I-cell_type
smooth	I-cell_type
muscle	I-cell_type
cells	I-cell_type
(	O
VSMCs	B-cell_type
)	O
undergoing	O
apoptosis	O
after	O
serum	O
withdrawal	O
.	O

In	O
this	O
study	O
,	O
using	O
a	O
chromogenic	O
assay	O
,	O
we	O
have	O
shown	O
thrombin	B-protein
generation	O
by	O
apoptotic	B-cell_type
VSMCs	I-cell_type
expressing	O
c-myc	B-protein
(	O
VSMC-myc	B-cell_line
)	O
with	O
an	O
area	O
under	O
the	O
thrombin	B-protein
-generation	O
curve	O
(	O
AUC	O
)	O
of	O
305	O
+/-	O
17	O
nmol	O
x	O
min/L	O
and	O
a	O
peak	O
thrombin	B-protein
(	O
PT	O
)	O
of	O
154	O
+/-	O
9	O
nmol/L	O
.	O

The	O
thrombin	B-protein
-generating	O
potential	O
of	O
the	O
apoptotic	B-cell_line
VSMC-myc	I-cell_line
cells	I-cell_line
was	O
greater	O
than	O
that	O
of	O
unactivated	B-cell_type
platelets	I-cell_type
(	O
P	O
=	O
.003	O
for	O
AUC	O
;	O
P	O
=	O
.0002	O
for	O
PT	O
)	O
and	O
similar	O
to	O
calcium-ionophore	O
activated	B-cell_type
platelets	I-cell_type
(	O
AUC	O
of	O
332	O
+/-	O
15	O
nmol	O
x	O
min/L	O
,	O
P	O
=	O
.3	O
;	O
PT	O
of	O
172	O
+/-	O
8	O
nmol/L	O
,	O
P	O
=	O
.2	O
)	O
.	O

Thrombin	B-protein
activation	O
was	O
also	O
seen	O
with	O
apoptotic	B-cell_type
human	I-cell_type
VSMCs	I-cell_type
(	O
AUC	O
of	O
211	O
+/-	O
8	O
nmol	O
x	O
min/L	O
;	O
PT	O
of	O
103	O
+/-	O
4	O
nmol/L	O
)	O
and	O
was	O
inhibited	O
by	O
annexin	O
V	O
(	O
P	O
<	O
.0001	O
for	O
AUC	O
and	O
PT	O
)	O
.	O

VSMC-myc	B-cell_line
cells	I-cell_line
maintained	O
in	O
serum	O
generated	O
less	O
thrombin	B-protein
than	O
after	O
serum	O
withdrawal	O
(	O
P	O
=	O
.0002	O
for	O
AUC	O
and	O
PT	O
)	O
.	O

VSMCs	B-cell_type
derived	O
from	O
human	O
coronary	O
atherosclerotic	O
plaques	O
that	O
apoptose	O
even	O
in	O
serum	O
also	O
generated	O
thrombin	B-protein
(	O
AUC	O
of	O
260	O
+/-	O
2	O
nmol	O
x	O
min/L	O
;	O
PT	O
of	O
128	O
+/-	O
4	O
nmol/L	O
)	O
.	O

We	O
conclude	O
that	O
apoptotic	B-cell_type
VSMCs	I-cell_type
possess	O
a	O
significant	O
thrombin	B-protein
-generating	O
capacity	O
secondary	O
to	O
phosphatidylserine	O
exposure	O
.	O

Apoptotic	O
cells	O
within	O
atherosclerotic	O
plaques	O
may	O
allow	O
local	O
thrombin	B-protein
activation	O
,	O
thereby	O
contributing	O
to	O
disease	O
progression	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Thrombin	NULL
Generation	NULL
by	NULL
Apoptotic	NULL
Vascular	NULL
Smooth	NULL
Muscle	NULL
Cells	NULL
By	NULL
Paul	NULL
D.	NULL
Flynn	NULL
,	NULL
Christopher	NULL
D.	NULL
Byrne	NULL
,	NULL
Trevor	NULL
P.	NULL
Baglin	NULL
,	NULL
Peter	NULL
L.	NULL
Weissberg	NULL
,	NULL
and	NULL
Martin	NULL
R.	NULL
Bennett	NULL
Thrombin	NULL
activation	NULL
requires	NULL
assembly	NULL
of	NULL
a	NULL
prothrombinase	NULL
complex	NULL
of	NULL
activated	NULL
coagulation	NULL
factors	NULL
on	NULL
an	NULL
anionic	NULL
phospholipid	NULL
surface	NULL
,	NULL
classically	NULL
provided	NULL
by	NULL
activated	NULL
platelets	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
anionic	NULL
phosphatidylserine	NULL
is	NULL
exposed	NULL
by	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
VSMCs	NULL
)	NULL
undergoing	NULL
apoptosis	NULL
after	NULL
serum	NULL
withdrawal	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
using	NULL
a	NULL
chromogenic	NULL
assay	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
thrombin	NULL
generation	NULL
by	NULL
apoptotic	NULL
VSMCs	NULL
expressing	NULL
c-mye	NULL
(	NULL
VSMC-myc	NULL
)	NULL
with	NULL
an	NULL
area	NULL
under	NULL
the	NULL
thrombin-generation	NULL
curve	NULL
(	NULL
AUC	NULL
)	NULL
of	NULL
305	NULL
+	NULL
17	NULL
nmol	NULL
:	NULL
min/L	NULL
and	NULL
a	NULL
peak	NULL
thrombin	NULL
(	NULL
PT	NULL
)	NULL
of	NULL
154	NULL
+	NULL
9	NULL
nmol/L	NULL
.	NULL

The	NULL
thrombin-generating	NULL
potential	NULL
of	NULL
the	NULL
apoptotic	NULL
VSMC-myce	NULL
cells	NULL
was	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
unactivated	NULL
platelets	NULL
(	NULL
P	NULL
=	NULL
.003	NULL
for	NULL
AUC	NULL
;	NULL
P	NULL
=	NULL
.0002	NULL
for	NULL
PT	NULL
)	NULL
and	NULL
similar	NULL
to	NULL
calcium-ionophore	NULL
activated	NULL
platelets	NULL
(	NULL
AUC	NULL
of	NULL
332	NULL
+	NULL
15	NULL
nmol	NULL
:	NULL
min/L	NULL
,	NULL
P	NULL
=	NULL
.3	NULL
;	NULL
PT	NULL
of	NULL
172	NULL
+	NULL
8	NULL
nmol/L	NULL
,	NULL
P=	NULL
.2	NULL
)	NULL
.	NULL

Thrombin	NULL
GROWING	NULL
BODY	NULL
OF	NULL
evidence	NULL
implicates	NULL
thrombin	NULL
in	NULL
vascular	NULL
disease	NULL
.	NULL

Thrombin	NULL
is	NULL
a	NULL
serine	NULL
protease	NULL
that	NULL
specifically	NULL
cleaves	NULL
fibrinogen	NULL
to	NULL
fibrin	NULL
,	NULL
thereby	NULL
stabilizing	NULL
newly	NULL
formed	NULL
clot	NULL
.	NULL

Thrombin	NULL
directly	NULL
activates	NULL
platelets	NULL
to	NULL
adhere	NULL
,	NULL
aggregate	NULL
,	NULL
and	NULL
release	NULL
the	NULL
contents	NULL
of	NULL
their	NULL
«	NULL
gran-ules	NULL
'	NULL
and	NULL
is	NULL
thereby	NULL
a	NULL
mediator	NULL
of	NULL
the	NULL
intravascular	NULL
coagulation	NULL
seen	NULL
in	NULL
acute	NULL
myocardial	NULL
infarction	NULL
and	NULL
unstable	NULL
angina	NULL
pectoris	NULL
.	NULL

Other	NULL
cellular	NULL
effects	NULL
of	NULL
thrombin	NULL
may	NULL
enhance	NULL
neointima	NULL
formation	NULL
,	NULL
including	NULL
increased	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cell	NULL
(	NULL
VSMC	NULL
)	NULL
proliferation	NULL
``	NULL
and	NULL
migration	NULL
,	NULL
``	NULL
possibly	NULL
through	NULL
upregulation	NULL
of	NULL
tissue-type	NULL
plasminogen	NULL
activator	NULL
and	NULL
the	NULL
urokinase	NULL
receptor	NULL
.	NULL
``	NULL

Leukocyte	NULL
adhesion	NULL
and	NULL
diape-desis	NULL
,	NULL
which	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
in	NULL
atherogenesis	NULL
,	NULL
may	NULL
also	NULL
be	NULL
enhanced	NULL
by	NULL
a	NULL
thrombin-mediated	NULL
increase	NULL
in	NULL
P-selectin	NULL
expression©®	NULL
and	NULL
gap	NULL
junction	NULL
formation	NULL
'	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Thrombin	NULL
induces	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
production	NULL
by	NULL
VSMCs®	NULL
and	NULL
is	NULL
therefore	NULL
chemotactic	NULL
to	NULL
monocytes	NULL
.	NULL
``	NULL

Thrombin	NULL
upregulates	NULL
plasminogen	NULL
activator	NULL
thereby	NULL
decreasing	NULL
fibrinolysis	NULL
,	NULL
and	NULL
en-dothelin	NULL
,	NULL
``	NULL
'	NULL
both	NULL
of	NULL
which	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
vascular	NULL
disease	NULL
.	NULL

The	NULL
thrombin	NULL
receptor	NULL
,	NULL
which	NULL
mediates	NULL
these	NULL
cellular	NULL
effects	NULL
,	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
atherosclerotic	NULL
lesions	NULL
``	NULL
and	NULL
in	NULL
the	NULL
neointima	NULL
produced	NULL
by	NULL
vascular	NULL
injury	NULL
.	NULL
``	NULL

Fibrin	NULL
,	NULL
an	NULL
end	NULL
product	NULL
of	NULL
thrombin	NULL
activity	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
within	NULL
atherosclerotic	NULL
plaques	NULL
.	NULL
``	NULL

The	NULL
production	NULL
of	NULL
active	NULL
thrombin	NULL
from	NULL
its	NULL
inactive	NULL
precursor	NULL
prothrombin	NULL
requires	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
prothrombi-	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
Medicine	NULL
,	NULL
Clinical	NULL
Biochemistry	NULL
,	NULL
and	NULL
Haematology	NULL
,	NULL
Addenbrooke	NULL
's	NULL
Hospital	NULL
,	NULL
Cambridge	NULL
,	NULL
UK	NULL
.	NULL

Submitted	NULL
September	NULL
9	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
February	NULL
3	NULL
,	NULL
1997	NULL
.	NULL

P.D.F	NULL
.	NULL

is	NULL
a	NULL
British	NULL
Heart	NULL
Foundation	NULL
(	NULL
BHF	NULL
)	NULL
Clinical	NULL
PhD	NULL
student	NULL
,	NULL
C.D.B	NULL
.	NULL

is	NULL
a	NULL
Medical	NULL
Research	NULL
Council	NULL
Clinician	NULL
Scientist	NULL
,	NULL
P.L.W	NULL
.	NULL

is	NULL
a	NULL
BHF	NULL
Professor	NULL
,	NULL
and	NULL
M.R.B	NULL
.	NULL

is	NULL
a	NULL
BHF	NULL
Clinician	NULL
Scientist	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Dr	NULL
Paul	NULL
D.	NULL
Flynn	NULL
,	NULL
University	NULL
of	NULL
Cambridge	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Box	NULL
157	NULL
,	NULL
Level	NULL
5	NULL
,	NULL
Addenbrooke	NULL
's	NULL
Hospital	NULL
,	NULL
Hills	NULL
Road	NULL
,	NULL
Cambridge	NULL
CB2	NULL
2QQ	NULL
,	NULL
UK	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/97/8912-0039	NULL
$	NULL
3.00/0	NULL
4378	NULL
activation	NULL
was	NULL
also	NULL
seen	NULL
with	NULL
apoptotic	NULL
human	NULL
VSMCs	NULL
(	NULL
AUC	NULL
of	NULL
211	NULL
+	NULL
8	NULL
nmol	NULL
:	NULL
min/L	NULL
;	NULL
PT	NULL
of	NULL
103	NULL
+	NULL
4	NULL
nmol/L	NULL
)	NULL
and	NULL
was	NULL
inhibited	NULL
by	NULL
annexin	NULL
V	NULL
(	NULL
P	NULL
<	NULL
.0001	NULL
for	NULL
AUC	NULL
and	NULL
PT	NULL
}	NULL
.	NULL

VSMC-mye	NULL
cells	NULL
maintained	NULL
in	NULL
serum	NULL
generated	NULL
less	NULL
thrombin	NULL
than	NULL
after	NULL
serum	NULL
withdrawal	NULL
(	NULL
P	NULL
=	NULL
.0002	NULL
for	NULL
AUC	NULL
and	NULL
PT	NULL
}	NULL
.	NULL

VSMCs	NULL
derived	NULL
from	NULL
human	NULL
coronary	NULL
atherosclerotic	NULL
plaques	NULL
that	NULL
apoptose	NULL
even	NULL
in	NULL
serum	NULL
also	NULL
generated	NULL
thrombin	NULL
(	NULL
AUC	NULL
of	NULL
260	NULL
+	NULL
2	NULL
nmol	NULL
-	NULL
min/L	NULL
;	NULL
PT	NULL
of	NULL
128	NULL
+	NULL
4	NULL
nmol/L	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
apoptotic	NULL
VSMCs	NULL
possess	NULL
a	NULL
significant	NULL
thrombin-generating	NULL
capacity	NULL
secondary	NULL
to	NULL
phosphatidylserine	NULL
exposure	NULL
.	NULL

Apoptotic	NULL
cells	NULL
within	NULL
atherosclerotic	NULL
plaques	NULL
may	NULL
allow	NULL
local	NULL
thrombin	NULL
activation	NULL
,	NULL
thereby	NULL
contributing	NULL
to	NULL
disease	NULL
pro-gression	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

nase	NULL
complex	NULL
incorporating	NULL
activated	NULL
coagulation	NULL
factor	NULL
X	NULL
on	NULL
an	NULL
anionic	NULL
phospholipid	NULL
surface	NULL
,	NULL
classically	NULL
provided	NULL
by	NULL
activated	NULL
platelets	NULL
.	NULL
``	NULL

''	NULL
Negatively	NULL
charged	NULL
phospholipids	NULL
,	NULL
such	NULL
as	NULL
phosphatidylserine	NULL
,	NULL
are	NULL
normally	NULL
restricted	NULL
to	NULL
the	NULL
inner	NULL
cytoplasmic	NULL
leaflet	NULL
of	NULL
the	NULL
lipid	NULL
bilayer	NULL
of	NULL
the	NULL
platelet	NULL
membrane	NULL
,	NULL
but	NULL
are	NULL
exposed	NULL
on	NULL
the	NULL
outer	NULL
surface	NULL
after	NULL
activation	NULL
.	NULL
``	NULL

The	NULL
mechanism	NULL
underlying	NULL
this	NULL
exposure	NULL
of	NULL
phosphatidylserine	NULL
is	NULL
incompletely	NULL
understood	NULL
,	NULL
but	NULL
is	NULL
invariably	NULL
accompanied	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
small	NULL
microparticles	NULL
of	NULL
membrane	NULL
at	NULL
the	NULL
platelet	NULL
surface	NULL
that	NULL
may	NULL
be	NULL
the	NULL
site	NULL
of	NULL
assembly	NULL
of	NULL
the	NULL
prothrombinase	NULL
complex	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Several	NULL
lines	NULL
of	NULL
evidence	NULL
using	NULL
phosphatidylserine-specific	NULL
phospholipases	NULL
,	NULL
``	NULL
artificial	NULL
phospholipid	NULL
vesicles	NULL
,	NULL
'	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
and	NULL
annexin	NULL
V	NULL
,	NULL
which	NULL
specifically	NULL
binds	NULL
exposed	NULL
phosphatidylserine	NULL
,	NULL
``	NULL
``	NULL
have	NULL
confirmed	NULL
that	NULL
phosphatidylserine	NULL
exposure	NULL
is	NULL
required	NULL
for	NULL
prothrombinase	NULL
activity	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
lymphocytes	NULL
undergoing	NULL
apoptosis	NULL
lose	NULL
membrane	NULL
phospholipid	NULL
asymmetry	NULL
with	NULL
consequent	NULL
phosphatidylserine	NULL
exposure	NULL
.	NULL
``	NULL

''	NULL
We	NULL
have	NULL
previously	NULL
described	NULL
the	NULL
production	NULL
of	NULL
rat	NULL
and	NULL
human	NULL
VSMC	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
the	NULL
proto-onco-gene	NULL
c-myc	NULL
or	NULL
the	NULL
adenovirus	NULL
ElA	NULL
gene	NULL
after	NULL
retrovirus-mediated	NULL
gene	NULL
transfer	NULL
.	NULL
``	NULL

''	NULL
These	NULL
VSMCs	NULL
undergo	NULL
repro-ducible	NULL
,	NULL
high	NULL
rates	NULL
of	NULL
apoptosis	NULL
after	NULL
serum	NULL
withdrawal	NULL
,	NULL
as	NULL
documented	NULL
by	NULL
their	NULL
characteristic	NULL
morphology	NULL
on	NULL
electron	NULL
microscopy	NULL
and	NULL
time-lapse	NULL
videomicroscopy	NULL
and	NULL
by	NULL
DNA	NULL
fragmentation	NULL
patterns	NULL
.	NULL

We	NULL
have	NULL
also	NULL
documented	NULL
phosphatidylserine	NULL
exposure	NULL
in	NULL
these	NULL
apoptotic	NULL
VSMCs	NULL
using	NULL
radiola-beled	NULL
annexin	NULL
V°*	NULL
and	NULL
shown	NULL
that	NULL
the	NULL
phosphatidylserine	NULL
exposure	NULL
partly	NULL
mediates	NULL
their	NULL
phagocytosis	NULL
by	NULL
adjacent	NULL
VSMCs	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
human	NULL
coronary	NULL
atherosclerotic	NULL
plaques	NULL
,	NULL
which	NULL
are	NULL
frequently	NULL
associated	NULL
with	NULL
areas	NULL
of	NULL
thrombosis	NULL
,	NULL
have	NULL
high	NULL
rates	NULL
of	NULL
apoptosis	NULL
of	NULL
both	NULL
VSMCs	NULL
and	NULL
macrophages	NULL
.	NULL
``	NULL

We	NULL
have	NULL
therefore	NULL
investigated	NULL
whether	NULL
apoptotic	NULL
VSMCs	NULL
provide	NULL
a	NULL
surface	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
active	NULL
thrombin	NULL
as	NULL
an	NULL
additional	NULL
consequence	NULL
of	NULL
their	NULL
phosphatidylserine	NULL
exposure	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

Reptilase	NULL
reagent	NULL
(	NULL
Batroxobin	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Pentapharm	NULL
Ltd	NULL
(	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
and	NULL
20	NULL
BU	NULL
was	NULL
reconstituted	NULL
in	NULL
0.5	NULL
mL	NULL
distilled	NULL
water	NULL
.	NULL

Chromogenic	NULL
substrate	NULL
$	NULL
2238	NULL
was	NULL
obtained	NULL
from	NULL
Chromogenix	NULL
AB	NULL
(	NULL
Mélndal	NULL
,	NULL
Sweden	NULL
)	NULL
,	NULL
reconstituted	NULL
to	NULL
4	NULL
mmol/L	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
4°C	NULL
.	NULL

Calcium	NULL
Ionophore	NULL
A23187	NULL
was	NULL
obtained	NULL
Blood	NULL
,	NULL
Vol	NULL
89	NULL
,	NULL
No	NULL
12	NULL
(	NULL
June	NULL
15	NULL
)	NULL
,	NULL
1997	NULL
:	NULL
pp	NULL
4378-4384	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

THROMBIN	NULL
GENERATION	NULL
BY	NULL
APOPTOTIC	NULL
VSMCs	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
reconstituted	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
at	NULL
400	NULL
mol/L	NULL
.	NULL

Russel	NULL
's	NULL
Viper	NULL
Venom	NULL
was	NULL
obtained	NULL
from	NULL
Diagnostic	NULL
Reagents	NULL
Ltd	NULL
(	NULL
Thame	NULL
,	NULL
Oxon	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
the	NULL
stock	NULL
solution	NULL
of	NULL
0.1	NULL
mg/	NULL
mL	NULL
in	NULL
immidazole	NULL
buffer	NULL
was	NULL
diluted	NULL
1	NULL
in	NULL
60	NULL
before	NULL
use	NULL
.	NULL

Human	NULL
recombinant	NULL
annexin	NULL
V	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
John	NULL
Tait	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

All	NULL
other	NULL
chemicals	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

-	NULL
VSMCs	NULL
were	NULL
isolated	NULL
from	NULL
thoracic	NULL
aortic	NULL
explants	NULL
of	NULL
6-week-old	NULL
Sprague-Dawley	NULL
rats	NULL
.	NULL

Normal	NULL
human	NULL
VSMCs	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
media	NULL
of	NULL
coronary	NULL
arteries	NULL
of	NULL
patients	NULL
undergoing	NULL
transplantation	NULL
for	NULL
nonischemic	NULL
cardiomyopathy	NULL
.	NULL

Patients	NULL
were	NULL
from	NULL
the	NULL
University	NULL
of	NULL
Washington	NULL
Medical	NULL
Center	NULL
transplantation	NULL
program	NULL
between	NULL
1987	NULL
and	NULL
1994	NULL
.	NULL

Plaque	NULL
VSMCs	NULL
from	NULL
primary	NULL
human	NULL
coronary	NULL
artery	NULL
plaques	NULL
were	NULL
obtained	NULL
from	NULL
patients	NULL
who	NULL
underwent	NULL
directional	NULL
coronary	NULL
atherectomy	NULL
(	NULL
Simpson	NULL
Coronary	NULL
Atherocath	NULL
;	NULL
Devices	NULL
for	NULL
Vascular	NULL
Intervention	NULL
Inc	NULL
,	NULL
Redwood	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
the	NULL
cardiac	NULL
catheterization	NULL
laboratory	NULL
of	NULL
the	NULL
University	NULL
of	NULL
Washington	NULL
Medical	NULL
Center	NULL
between	NULL
1990	NULL
and	NULL
1992	NULL
.	NULL

Isolation	NULL
of	NULL
cells	NULL
from	NULL
these	NULL
tissues	NULL
and	NULL
histology	NULL
of	NULL
the	NULL
tissues	NULL
of	NULL
origin	NULL
were	NULL
as	NULL
described	NULL
before	NULL
.	NULL
``	NULL

''	NULL
Cells	NULL
were	NULL
cultured	NULL
in	NULL
M199	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Life	NULL
Technologies	NULL
Inc	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
Flow	NULL
,	NULL
McLean	NULL
,	NULL
VA	NULL
)	NULL
and	NULL
equilibrated	NULL
with	NULL
95	NULL
%	NULL
air	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Subconfluent	NULL
cells	NULL
were	NULL
analyzed	NULL
immu-nocytochemically	NULL
to	NULL
confirm	NULL
smooth	NULL
muscle	NULL
cell	NULL
origin	NULL
(	NULL
«	NULL
-actin	NULL
posi-tive	NULL
,	NULL
vimentin-positive	NULL
,	NULL
von	NULL
Willebrand	NULL
factor-negative	NULL
,	NULL
desmin-neg-ative	NULL
,	NULL
and	NULL
smooth	NULL
muscle	NULL
myosin-negative	NULL
)	NULL
.	NULL

Cells	NULL
at	NULL
passage	NULL
5	NULL
were	NULL
used	NULL
for	NULL
experiments	NULL
and	NULL
retrovirus	NULL
infections	NULL
.	NULL

Production	NULL
of	NULL
retrovirus-infected	NULL
cell	NULL
lines	NULL
.	NULL

-	NULL
The	NULL
retrovirus	NULL
constructs	NULL
used	NULL
to	NULL
create	NULL
VSMC	NULL
cell	NULL
lines	NULL
constitutively	NULL
expressing	NULL
c-mye	NULL
and	NULL
adenovirus	NULL
ElA	NULL
(	NULL
128	NULL
)	NULL
were	NULL
based	NULL
on	NULL
the	NULL
pDORneo	NULL
and	NULL
pBabepuro	NULL
retrovirus	NULL
vectors	NULL
``	NULL
and	NULL
contained	NULL
full-length	NULL
cDNAs	NULL
of	NULL
each	NULL
species	NULL
.	NULL
``	NULL

''	NULL
VSMCs	NULL
were	NULL
infected	NULL
with	NULL
retrovirus	NULL
vectors	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Twenty-four	NULL
hours	NULL
after	NULL
infection	NULL
,	NULL
resistant	NULL
cells	NULL
were	NULL
selected	NULL
in	NULL
500	NULL
pg/mL	NULL
(	NULL
rat	NULL
cells	NULL
)	NULL
or	NULL
750	NULL
pg/mL	NULL
(	NULL
human	NULL
cells	NULL
)	NULL
of	NULL
G418	NULL
(	NULL
Geneticin	NULL
;	NULL
GIBCO	NULL
)	NULL
.	NULL

Resistant	NULL
cell	NULL
populations	NULL
were	NULL
used	NULL
for	NULL
experiments	NULL
not	NULL
less	NULL
than	NULL
6	NULL
weeks	NULL
after	NULL
infection	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
antibiotics	NULL
at	NULL
all	NULL
times	NULL
.	NULL

Time-lapse	NULL
videomicroscopy	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
prepared	NULL
for	NULL
videomicroscopy	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
medium	NULL
containing	NULL
0	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
this	NULL
latter	NULL
medium	NULL
.	NULL

Flasks	NULL
were	NULL
gassed	NULL
with	NULL
95	NULL
%	NULL
air	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
every	NULL
24	NULL
hours	NULL
and	NULL
sealed	NULL
.	NULL

An	NULL
Olympus	NULL
OM-70	NULL
microscope	NULL
(	NULL
Olympus	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
was	NULL
enclosed	NULL
in	NULL
a	NULL
plastic	NULL
environment	NULL
chamber	NULL
and	NULL
maintained	NULL
at	NULL
37°C	NULL
by	NULL
an	NULL
external	NULL
heater	NULL
.	NULL

The	NULL
time-lapse	NULL
equipment	NULL
consisted	NULL
of	NULL
a	NULL
Sony	NULL
92D	NULL
CCD	NULL
camera	NULL
(	NULL
Sony	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
with	NULL
a	NULL
Panasonic	NULL
6730	NULL
time-lapse	NULL
video	NULL
recorder	NULL
(	NULL
Panasonic	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Films	NULL
were	NULL
analyzed	NULL
for	NULL
morphology	NULL
of	NULL
apoptosis	NULL
and	NULL
cell	NULL
death	NULL
rates	NULL
as	NULL
previously	NULL
de-scribed	NULL
,	NULL
``	NULL
``	NULL
using	NULL
an	NULL
observer	NULL
blind	NULL
to	NULL
cell	NULL
type	NULL
and	NULL
treatment	NULL
condi-tions	NULL
.	NULL

Apoptotic	NULL
cell	NULL
death	NULL
events	NULL
were	NULL
scored	NULL
midway	NULL
between	NULL
the	NULL
last	NULL
appearance	NULL
of	NULL
normality	NULL
and	NULL
the	NULL
point	NULL
at	NULL
which	NULL
the	NULL
cell	NULL
became	NULL
fully	NULL
detached	NULL
and	NULL
fragmented	NULL
,	NULL
an	NULL
interval	NULL
of	NULL
typically	NULL
60	NULL
to	NULL
90	NULL
minutes	NULL
.	NULL

Each	NULL
individual	NULL
cell	NULL
culture	NULL
was	NULL
analyzed	NULL
in	NULL
duplicate	NULL
as	NULL
a	NULL
minimum	NULL
(	NULL
plaque	NULL
VSMCs	NULL
,	NULL
n	NULL
=	NULL
8	NULL
;	NULL
normal	NULL
coronary	NULL
VSMCs	NULL
,	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

Platelets	NULL
and	NULL
activated	NULL
platelets	NULL
.	NULL

-	NULL
Blood	NULL
was	NULL
obtained	NULL
from	NULL
one	NULL
of	NULL
the	NULL
authors	NULL
(	NULL
P.D.F	NULL
.	NULL
)	NULL

by	NULL
collection	NULL
into	NULL
0.109	NULL
mol/L	NULL
sodium	NULL
citrate	NULL
.	NULL

Platelet-rich	NULL
plasma	NULL
was	NULL
obtained	NULL
by	NULL
centrifugation	NULL
at	NULL
150g	NULL
for	NULL
8	NULL
minutes	NULL
and	NULL
the	NULL
platelet	NULL
count	NULL
and	NULL
volumes	NULL
were	NULL
measured	NULL
using	NULL
a	NULL
Coulter	NULL
Model	NULL
STKS	NULL
(	NULL
Coulter	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Platelets	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
PBS	NULL
,	NULL
0.05	NULL
%	NULL
human	NULL
albumin	NULL
,	NULL
and	NULL
3	NULL
mmol/L	NULL
sodium	NULL
azide	NULL
)	NULL
and	NULL
recovered	NULL
by	NULL
centrifugation	NULL
at	NULL
1,000g	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

Platelets	NULL
were	NULL
finally	NULL
resuspended	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
375	NULL
x	NULL
10°/L	NULL
,	NULL
giving	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
X	NULL
10°/L	NULL
in	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
.	NULL

Activation	NULL
was	NULL
achieved	NULL
by	NULL
vortexing	NULL
the	NULL
resus-	NULL
4379	NULL
pended	NULL
platelets	NULL
with	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
4	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
and	NULL
0.5	NULL
mmol/L	NULL
calcium	NULL
chloride	NULL
.	NULL

Apoptotic	NULL
bodies	NULL
.	NULL

-	NULL
To	NULL
generate	NULL
apoptotic	NULL
VSMCs	NULL
,	NULL
near-confluent	NULL
VSMC	NULL
cultures	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
medium	NULL
with	NULL
0	NULL
%	NULL
FCS	NULL
and	NULL
incubated	NULL
in	NULL
this	NULL
medium	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

Culture	NULL
flasks	NULL
were	NULL
tapped	NULL
repeatedly	NULL
to	NULL
dislodge	NULL
apoptotic	NULL
bodies	NULL
that	NULL
were	NULL
recovered	NULL
in	NULL
the	NULL
supernatant	NULL
medium	NULL
.	NULL

The	NULL
bodies	NULL
were	NULL
counted	NULL
with	NULL
a	NULL
hemacytometer	NULL
using	NULL
a	NULL
1	NULL
in	NULL
2	NULL
dilution	NULL
in	NULL
0.025	NULL
%	NULL
trypan	NULL
blue	NULL
.	NULL

On	NULL
all	NULL
occa-sions	NULL
,	NULL
the	NULL
bodies	NULL
excluded	NULL
trypan	NULL
blue	NULL
.	NULL

The	NULL
apoptotic	NULL
bodies	NULL
were	NULL
thereafter	NULL
treated	NULL
exactly	NULL
as	NULL
the	NULL
platelet-rich	NULL
plasma	NULL
,	NULL
being	NULL
washed	NULL
twice	NULL
in	NULL
buffer	NULL
C	NULL
,	NULL
recovered	NULL
by	NULL
centrifugation	NULL
at	NULL
1,000g	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
and	NULL
finally	NULL
resuspended	NULL
in	NULL
buffer	NULL
C	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
16.8	NULL
x	NULL
10°/L	NULL
,	NULL
except	NULL
where	NULL
otherwise	NULL
stated	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
was	NULL
rechecked	NULL
on	NULL
the	NULL
hemacytometer	NULL
.	NULL

This	NULL
gave	NULL
a	NULL
concentration	NULL
in	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
of	NULL
2.24	NULL
X	NULL
10°/L	NULL
,	NULL
calculated	NULL
to	NULL
give	NULL
an	NULL
equivalent	NULL
surface	NULL
area	NULL
to	NULL
50	NULL
x	NULL
10°/L	NULL
platelets	NULL
.	NULL

These	NULL
calculations	NULL
assume	NULL
an	NULL
average	NULL
platelet	NULL
volume	NULL
of	NULL
8	NULL
fL	NULL
(	NULL
as	NULL
confirmed	NULL
on	NULL
the	NULL
Coulter	NULL
Counter	NULL
)	NULL
,	NULL
an	NULL
average	NULL
apoptotic	NULL
body	NULL
radius	NULL
of	NULL
5	NULL
um	NULL
(	NULL
based	NULL
on	NULL
previous	NULL
studies*	NULL
``	NULL
)	NULL
,	NULL
and	NULL
both	NULL
platelets	NULL
and	NULL
apoptotic	NULL
bodies	NULL
to	NULL
be	NULL
spheres	NULL
.	NULL

Defibrinated	NULL
plasma	NULL
.	NULL

Plasma	NULL
from	NULL
healthy	NULL
donors	NULL
was	NULL
pooled	NULL
(	NULL
1	NULL
L	NULL
)	NULL
and	NULL
defibrinated	NULL
by	NULL
adding	NULL
1	NULL
part	NULL
reptilase	NULL
to	NULL
200	NULL
parts	NULL
plasma	NULL
and	NULL
incubating	NULL
at	NULL
37°C	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
fibrin	NULL
clot	NULL
was	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
2,000g	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
remaining	NULL
plasma	NULL
was	NULL
filtered	NULL
through	NULL
sterile	NULL
0.2-um	NULL
filters	NULL
to	NULL
remove	NULL
any	NULL
remaining	NULL
platelet	NULL
microparticles	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
in	NULL
1-mL	NULL
aliquots	NULL
.	NULL

Thrombin	NULL
generation	NULL
assay	NULL
.	NULL

|	NULL
Phospholipid-dependent	NULL
thrombin	NULL
generation	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
assay	NULL
as	NULL
previously	NULL
validated	NULL
and	NULL
described	NULL
.	NULL

``	NULL
>	NULL
*	NULL
``	NULL
Briefly	NULL
,	NULL
10	NULL
uL	NULL
Russel	NULL
's	NULL
Viper	NULL
Venom	NULL
was	NULL
added	NULL
to	NULL
200	NULL
gL	NULL
defibrinated	NULL
,	NULL
0.2	NULL
wm	NULL
filtered	NULL
plasma	NULL
followed	NULL
by	NULL
40	NULL
uL	NULL
of	NULL
the	NULL
suspension	NULL
of	NULL
freshly	NULL
prepared	NULL
platelets	NULL
or	NULL
apoptotic	NULL
bodies	NULL
.	NULL

Exactly	NULL
30	NULL
seconds	NULL
later	NULL
,	NULL
50	NULL
gL	NULL
0.1	NULL
mol/L	NULL
calcium	NULL
chloride	NULL
was	NULL
added	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
waterbath	NULL
.	NULL

At	NULL
30-second	NULL
intervals	NULL
,	NULL
10-4L	NULL
aliquots	NULL
were	NULL
removed	NULL
and	NULL
added	NULL
to	NULL
tubes	NULL
containing	NULL
465	NULL
gL	NULL
buffer	NULL
B	NULL
(	NULL
0.05	NULL
mol/L	NULL
Tris-HCI	NULL
,	NULL
0.1	NULL
mol/L	NULL
sodium	NULL
chloride	NULL
,	NULL
0.5	NULL
%	NULL
bovine	NULL
albumin	NULL
,	NULL
20	NULL
mmol/L	NULL
sodium	NULL
EDTA	NULL
)	NULL
and	NULL
25	NULL
pL	NULL
of	NULL
$	NULL
2238	NULL
(	NULL
a	NULL
chromogenic	NULL
substrate	NULL
specific	NULL
for	NULL
thrombin	NULL
)	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
gmol/L	NULL
.	NULL

After	NULL
4	NULL
minutes	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
300	NULL
mL	NULL
of	NULL
1	NULL
mol/L	NULL
citric	NULL
acid	NULL
.	NULL

Three	NULL
hundred	NULL
microliters	NULL
of	NULL
the	NULL
resulting	NULL
solution	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
microtitre	NULL
well	NULL
plate	NULL
and	NULL
the	NULL
absorbance	NULL
at	NULL
405	NULL
nm	NULL
was	NULL
read	NULL
in	NULL
a	NULL
Titertek	NULL
Multiskan	NULL
MCC	NULL
plate	NULL
reader	NULL
(	NULL
ICN	NULL
Biomedicals	NULL
Ltd	NULL
,	NULL
Thame	NULL
,	NULL
Oxon	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Conversion	NULL
of	NULL
the	NULL
results	NULL
to	NULL
nanomoles	NULL
per	NULL
liter	NULL
of	NULL
thrombin	NULL
was	NULL
calculated	NULL
from	NULL
a	NULL
previously	NULL
derived	NULL
standard	NULL
curve	NULL
using	NULL
pure	NULL
human	NULL
a-thrombin	NULL
.	NULL
``	NULL

Hirudin	NULL
and	NULL
annexin	NULL
V	NULL
studies	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
hirudin	NULL
on	NULL
the	NULL
cleavage	NULL
of	NULL
$	NULL
2238	NULL
was	NULL
studied	NULL
by	NULL
preparing	NULL
a	NULL
1.5-fold	NULL
molar	NULL
excess	NULL
.	NULL

Hirudin	NULL
(	NULL
100	NULL
U	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
gL	NULL
0.1	NULL
mol/L	NULL
calcium	NULL
chloride	NULL
,	NULL
and	NULL
50	NULL
gL	NULL
of	NULL
this	NULL
solution	NULL
was	NULL
added	NULL
in	NULL
place	NULL
of	NULL
the	NULL
0.1	NULL
mol/L	NULL
calcium	NULL
chloride	NULL
in	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
annexin	NULL
V	NULL
was	NULL
studied	NULL
by	NULL
adding	NULL
2.3	NULL
wL	NULL
of	NULL
a	NULL
stock	NULL
solution	NULL
(	NULL
217	NULL
pmol/L	NULL
)	NULL
to	NULL
97.7	NULL
uL	NULL
of	NULL
the	NULL
resuspended	NULL
apoptotic	NULL
bodies	NULL
to	NULL
give	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
5	NULL
pmol/L	NULL
.	NULL

The	NULL
resulting	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
.	NULL

Thrombin	NULL
generation	NULL
assay	NULL
for	NULL
monolayers	NULL
.	NULL

-	NULL
The	NULL
thrombin	NULL
generation	NULL
assay	NULL
as	NULL
described	NULL
relies	NULL
on	NULL
the	NULL
detachment	NULL
of	NULL
apoptotic	NULL
bodies	NULL
into	NULL
the	NULL
supernatant	NULL
medium	NULL
.	NULL

To	NULL
determine	NULL
thrombin	NULL
generation	NULL
by	NULL
nonapoptotic	NULL
VSMCs	NULL
that	NULL
do	NULL
not	NULL
detach	NULL
required	NULL
adaptation	NULL
of	NULL
the	NULL
assay	NULL
for	NULL
use	NULL
with	NULL
monolayers	NULL
.	NULL

VSMCs	NULL
were	NULL
grown	NULL
in	NULL
6-well	NULL
plates	NULL
until	NULL
confluent	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
gently	NULL
washed	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
either	NULL
with	NULL
medium	NULL
and	NULL
0	NULL
%	NULL
FCS	NULL
or	NULL
with	NULL
control	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

After	NULL
serum	NULL
deprivation	NULL
,	NULL
time-lapse	NULL
videomicroscopy	NULL
shows	NULL
a	NULL
sequence	NULL
of	NULL
changes	NULL
beginning	NULL
with	NULL
cell	NULL
retraction	NULL
,	NULL
followed	NULL
within	NULL
a	NULL
few	NULL
minutes	NULL
by	NULL
intense	NULL
membrane	NULL
activity	NULL
with	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4380	NULL
blebbing	NULL
and	NULL
apoptotic	NULL
body	NULL
formation	NULL
.	NULL
``	NULL

The	NULL
first	NULL
cells	NULL
undergo	NULL
these	NULL
changes	NULL
about	NULL
15	NULL
minutes	NULL
after	NULL
the	NULL
removal	NULL
of	NULL
serum	NULL
,	NULL
with	NULL
a	NULL
stochastic	NULL
recruitment	NULL
of	NULL
cells	NULL
thereafter	NULL
.	NULL

We	NULL
chose	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
4	NULL
hours	NULL
.	NULL

Counting	NULL
of	NULL
the	NULL
recovered	NULL
supernatant	NULL
on	NULL
the	NULL
hemacytometer	NULL
over	NULL
this	NULL
period	NULL
showed	NULL
that	NULL
no	NULL
apoptotic	NULL
bodies	NULL
had	NULL
detached	NULL
.	NULL

After	NULL
4	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
plates	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
wa-terbath	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
supernatant	NULL
medium	NULL
was	NULL
gently	NULL
removed	NULL
and	NULL
stored	NULL
for	NULL
subsequent	NULL
cell	NULL
counting	NULL
on	NULL
the	NULL
hemacytometer	NULL
,	NULL
and	NULL
each	NULL
well	NULL
was	NULL
gently	NULL
washed	NULL
once	NULL
with	NULL
5	NULL
mL	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
Russel	NULL
's	NULL
Viper	NULL
Venom	NULL
was	NULL
added	NULL
to	NULL
480	NULL
uL	NULL
of	NULL
defibrinated	NULL
0.2-um	NULL
filtered	NULL
plasma	NULL
,	NULL
followed	NULL
by	NULL
100	NULL
gL	NULL
of	NULL
0.1	NULL
mol/L	NULL
calcium	NULL
chloride	NULL
.	NULL

Thirty	NULL
seconds	NULL
later	NULL
,	NULL
this	NULL
activated	NULL
plasma	NULL
was	NULL
transferred	NULL
to	NULL
each	NULL
well	NULL
with	NULL
continuous	NULL
gentle	NULL
swirling	NULL
to	NULL
ensure	NULL
complete	NULL
coverage	NULL
of	NULL
the	NULL
monolayer	NULL
.	NULL

At	NULL
30-second	NULL
intervals	NULL
,	NULL
10-uL	NULL
aliquots	NULL
were	NULL
removed	NULL
and	NULL
added	NULL
at	NULL
37°C	NULL
to	NULL
tubes	NULL
containing	NULL
490	NULL
L.	NULL
of	NULL
the	NULL
buffered	NULL
chromogenic	NULL
substrate	NULL
$	NULL
2238	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
chromogenic	NULL
reaction	NULL
was	NULL
stopped	NULL
after	NULL
4	NULL
minutes	NULL
at	NULL
37°C	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
300	NULL
L	NULL
of	NULL
1	NULL
mol/L	NULL
citric	NULL
acid	NULL
,	NULL
and	NULL
the	NULL
absorbance	NULL
was	NULL
read	NULL
as	NULL
before	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

Results	NULL
are	NULL
quoted	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
.	NULL

Comparisons	NULL
between	NULL
groups	NULL
were	NULL
performed	NULL
using	NULL
Student	NULL
's	NULL
un-paired	NULL
assuming	NULL
equal	NULL
variances	NULL
on	NULL
the	NULL
untransformed	NULL
data	NULL
,	NULL
in	NULL
which	NULL
a	NULL
prior	NULL
E-test	NULL
showed	NULL
similar	NULL
variances	NULL
,	NULL
and	NULL
on	NULL
logarithmically	NULL
transformed	NULL
data	NULL
elsewhere	NULL
as	NULL
stated	NULL
.	NULL

Calculations	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Microsoft	NULL
Excel	NULL
statistics	NULL
package	NULL
(	NULL
Microsoft	NULL
Corp	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

RESULTS	NULL
Thrombin	NULL
generation	NULL
by	NULL
apoptotic	NULL
VSMCs	NULL
.	NULL

Apoptosis	NULL
was	NULL
induced	NULL
by	NULL
serum	NULL
deprivation	NULL
of	NULL
a	NULL
rat	NULL
VSMC	NULL
cell	NULL
line	NULL
expressing	NULL
human	NULL
c-myc	NULL
(	NULL
VSMC-myc	NULL
)	NULL
,	NULL
a	NULL
gene	NULL
product	NULL
known	NULL
to	NULL
enhance	NULL
apoptosis	NULL
,	NULL
and	NULL
the	NULL
apoptotic	NULL
bodies	NULL
produced	NULL
over	NULL
24	NULL
hours	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
78.2	NULL
%	NULL
+	NULL
9.2	NULL
%	NULL
of	NULL
VSMC-mye	NULL
cells	NULL
undergo	NULL
apoptosis	NULL
over	NULL
24	NULL
hours	NULL
after	NULL
serum	NULL
withdrawal	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
time-lapse	NULL
videomicroscopy	NULL
.	NULL
``	NULL

''	NULL
'	NULL
Figure	NULL
1	NULL
shows	NULL
the	NULL
thrombin	NULL
generation	NULL
curve	NULL
produced	NULL
by	NULL
2.24	NULL
%	NULL
10°/L	NULL
apoptotic	NULL
bodies	NULL
,	NULL
along	NULL
with	NULL
the	NULL
curves	NULL
generated	NULL
by	NULL
50	NULL
x	NULL
10°/L	NULL
platelets	NULL
and	NULL
calcium	NULL
ionophore	NULL
activated	NULL
platelets	NULL
and	NULL
buffer	NULL
C	NULL
alone	NULL
.	NULL

These	NULL
concentrations	NULL
were	NULL
chosen	NULL
,	NULL
as	NULL
discussed	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
to	NULL
approximate	NULL
the	NULL
surface	NULL
area	NULL
of	NULL
platelets	NULL
and	NULL
apoptotic	NULL
bodies	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

Thrombin	NULL
generation	NULL
was	NULL
complete	NULL
by	NULL
3	NULL
minutes	NULL
,	NULL
and	NULL
for	NULL
further	NULL
statistical	NULL
comparison	NULL
the	NULL
area	NULL
under	NULL
the	NULL
curve	NULL
to	NULL
3	NULL
minutes	NULL
(	NULL
AUC	NULL
)	NULL
and	NULL
the	NULL
peak	NULL
thrombin	NULL
concentration	NULL
were	NULL
calculated	NULL
,	NULL
as	NULL
recorded	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Thrombin	NULL
generation	NULL
by	NULL
the	NULL
apoptotic	NULL
bodies	NULL
was	NULL
significantly	NULL
greater	NULL
than	NULL
that	NULL
seen	NULL
with	NULL
buffer	NULL
C	NULL
alone	NULL
(	NULL
P	NULL
<	NULL
.0001	NULL
for	NULL
logarithmically	NULL
transformed	NULL
AUC	NULL
and	NULL
peak	NULL
thrombin	NULL
,	NULL
two-tailed	NULL
H-test	NULL
)	NULL
or	NULL
with	NULL
platelets	NULL
(	NULL
P	NULL
=	NULL
.003	NULL
for	NULL
AUC	NULL
and	NULL
P	NULL
=	NULL
.0002	NULL
for	NULL
peak	NULL
thrombin	NULL
,	NULL
two-tailed	NULL
#	NULL
test	NULL
)	NULL
and	NULL
of	NULL
similar	NULL
magnitude	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
activated	NULL
platelets	NULL
(	NULL
P	NULL
=	NULL
.3	NULL
for	NULL
AUC	NULL
and	NULL
P	NULL
=	NULL
.2	NULL
for	NULL
peak	NULL
thrombin	NULL
,	NULL
two-tailed	NULL
Table	NULL
1	NULL
also	NULL
shows	NULL
a	NULL
clear	NULL
correlation	NULL
between	NULL
the	NULL
concentration	NULL
of	NULL
apoptotic	NULL
bodies	NULL
and	NULL
thrombin	NULL
generation	NULL
(	NULL
r	NULL
=	NULL
.965	NULL
for	NULL
AUC	NULL
and	NULL
r	NULL
=	NULL
.978	NULL
for	NULL
peak	NULL
thrombin	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
thrombin	NULL
generation	NULL
was	NULL
restricted	NULL
to	NULL
rat	NULL
VSMCs	NULL
or	NULL
VSMCs	NULL
expressing	NULL
c-myc	NULL
,	NULL
human	NULL
VSMCs	NULL
expressing	NULL
the	NULL
adenovirus	NULL
gene	NULL
E1A	NULL
,	NULL
another	NULL
pro-apoptotic	NULL
gene	NULL
product	NULL
,	NULL
were	NULL
also	NULL
studied	NULL
.	NULL

Hu-	NULL
FLYNN	NULL
ET	NULL
AL	NULL
Thrombin	NULL
(	NULL
nmoVL	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fig	NULL
1	NULL
.	NULL

Thrombin	NULL
generation	NULL
curves	NULL
for	NULL
platelets	NULL
and	NULL
VSMCs	NULL
.	NULL

Apoptosis	NULL
was	NULL
induced	NULL
in	NULL
VSMC-myc	NULL
cells	NULL
by	NULL
serum	NULL
deprivation	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
detached	NULL
apoptotic	NULL
bodies	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
to	NULL
give	NULL
a	NULL
final	NULL
concentration	NULL
in	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
of	NULL
2.24	NULL
x	NULL
10°/L	NULL
.	NULL

Thrombin	NULL
generation	NULL
was	NULL
measured	NULL
for	NULL
6	NULL
minutes	NULL
(	NULL
C	NULL
)	NULL
and	NULL
compared	NULL
with	NULL
50	NULL
x	NULL
10°/L	NULL
unactivated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
calcium-ionophore	NULL
activated	NULL
(	NULL
«	NULL
)	NULL
platelets	NULL
or	NULL
buffer	NULL
C	NULL
alone	NULL
(	NULL
A	NULL
)	NULL
.	NULL

man	NULL
VSMC-E1A	NULL
cells	NULL
(	NULL
11.7	NULL
%	NULL
+	NULL
1.2	NULL
%	NULL
)	NULL
undergo	NULL
apoptosis	NULL
over	NULL
24	NULL
hours	NULL
after	NULL
serum	NULL
withdrawal	NULL
(	NULL
M.R.B	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
AUC	NULL
and	NULL
the	NULL
peak	NULL
thrombin	NULL
for	NULL
apoptotic	NULL
human	NULL
VSMC-E1A	NULL
cells	NULL
were	NULL
significantly	NULL
greater	NULL
than	NULL
for	NULL
buffer	NULL
C	NULL
(	NULL
P	NULL
<	NULL
.0001	NULL
,	NULL
one-tailed	NULL
t-test	NULL
)	NULL
,	NULL
but	NULL
were	NULL
significantly	NULL
less	NULL
than	NULL
for	NULL
the	NULL
VSMC-myc	NULL
cells	NULL
in	NULL
0	NULL
%	NULL
serum	NULL
(	NULL
P	NULL
=	NULL
.04	NULL
for	NULL
AUC	NULL
and	NULL
P	NULL
=	NULL
.03	NULL
for	NULL
peak	NULL
thrombin	NULL
,	NULL
two-tailed	NULL
t-test	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
it	NULL
was	NULL
the	NULL
process	NULL
of	NULL
apoptosis	NULL
per	NULL
se	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
species	NULL
of	NULL
origin	NULL
of	NULL
the	NULL
VSMCs	NULL
or	NULL
the	NULL
pro-apoptotic	NULL
gene	NULL
product	NULL
present	NULL
,	NULL
that	NULL
was	NULL
responsible	NULL
for	NULL
thrombin	NULL
generation	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
thrombin	NULL
generation	NULL
was	NULL
measured	NULL
by	NULL
cleavage	NULL
of	NULL
the	NULL
chromogenic	NULL
substrate	NULL
$	NULL
2238	NULL
,	NULL
which	NULL
may	NULL
not	NULL
be	NULL
completely	NULL
specific	NULL
for	NULL
thrombin	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
50	NULL
U	NULL
of	NULL
hirudin	NULL
,	NULL
which	NULL
antagonizes	NULL
thrombin	NULL
by	NULL
directly	NULL
binding	NULL
to	NULL
the	NULL
active	NULL
site	NULL
,	NULL
reduced	NULL
the	NULL
AUC	NULL
for	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
(	NULL
1.32	NULL
X	NULL
10°/L	NULL
)	NULL
from	NULL
267.0	NULL
+	NULL
5.4	NULL
nmol	NULL
-	NULL
min/L	NULL
to	NULL
15.2	NULL
+	NULL
0.8	NULL
nmol	NULL
-	NULL
min/L	NULL
(	NULL
P	NULL
=	NULL
.0005	NULL
,	NULL
one-tailed	NULL
#	NULL
-test	NULL
)	NULL
,	NULL
and	NULL
the	NULL
peak	NULL
thrombin	NULL
from	NULL
130.9	NULL
+	NULL
11.1	NULL
to	NULL
6.3	NULL
+	NULL
0.5	NULL
(	NULL
P	NULL
=	NULL
.001	NULL
for	NULL
logarithmically	NULL
transformed	NULL
data	NULL
,	NULL
one-tailed	NULL
#	NULL
-test	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
confirms	NULL
that	NULL
it	NULL
is	NULL
thrombin	NULL
that	NULL
is	NULL
generated	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
apoptotic	NULL
VSMCs	NULL
.	NULL

Effect	NULL
of	NULL
annexin	NULL
V	NULL
on	NULL
thrombin	NULL
generation	NULL
by	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
thrombin	NULL
generated	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

THROMBIN	NULL
GENERATION	NULL
BY	NULL
APOPTOTIC	NULL
VSMCs	NULL
Table	NULL
1	NULL
.	NULL

Thrombin	NULL
Generation	NULL
by	NULL
Apoptotic	NULL
VSMCs	NULL
and	NULL
Platelets	NULL
No	NULL
.	NULL

of	NULL
AUC	NULL
Peak	NULL
Thrombin	NULL
Experiments	NULL
|	NULL
(	NULL
nmol	NULL
-	NULL
min/L	NULL
}	NULL
{	NULL
nmol/L	NULL
)	NULL
Buffer	NULL
C	NULL
8	NULL
43.8	NULL
+	NULL
3.4*	NULL
-	NULL
26.3	NULL
+	NULL
2.5*	NULL
Platelets	NULL
14	NULL
220.8	NULL
+	NULL
14.8*	NULL
98.6	NULL
+	NULL
7.4*	NULL
Activated	NULL
platelets	NULL
15	NULL
331.5	NULL
+	NULL
15.1t	NULL
172.5	NULL
+	NULL
7.8t	NULL
Apoptotic	NULL
VSMC-myc	NULL
cells	NULL
(	NULL
2.24	NULL
x	NULL
10°/L	NULL
)	NULL
8	NULL
304.6	NULL
+	NULL
16.9	NULL
154.5	NULL
+	NULL
9.0	NULL
Apoptotic	NULL
VSMC-myc	NULL
cells	NULL
(	NULL
1.32	NULL
x	NULL
10°/L	NULL
)	NULL
2	NULL
267.0	NULL
+	NULL
5.4	NULL
-	NULL
130.9	NULL
+	NULL
11.1	NULL
Apoptotic	NULL
VSMC-myc	NULL
cells	NULL
(	NULL
0.73	NULL
x	NULL
10°/L	NULL
)	NULL
2	NULL
170.0	NULL
+	NULL
3.2	NULL
75.8	NULL
+	NULL
1.0	NULL
Apoptotic	NULL
VSMC-myc	NULL
cells	NULL
(	NULL
0.11	NULL
x	NULL
10°/L	NULL
)	NULL
2	NULL
90.4	NULL
+	NULL
0.4	NULL
39.2	NULL
+	NULL
0.7	NULL
Apoptotic	NULL
human	NULL
E1A	NULL
cells	NULL
2	NULL
211.0	NULL
+	NULL
8.5	NULL
%	NULL
1028	NULL
+	NULL
4.1	NULL
%	NULL
Apoptotis	NULL
was	NULL
induced	NULL
by	NULL
serum	NULL
starvation	NULL
of	NULL
rat	NULL
VSMCs	NULL
expressing	NULL
c-myc	NULL
or	NULL
normal	NULL
human	NULL
coronary	NULL
VSMCs	NULL
expressing	NULL
the	NULL
adenovirus	NULL
gene	NULL
E1A	NULL
.	NULL

Apoptotic	NULL
cells	NULL
were	NULL
suspended	NULL
to	NULL
give	NULL
an	NULL
assay	NULL
concentration	NULL
of	NULL
2.24	NULL
x	NULL
10°/L	NULL
(	NULL
except	NULL
where	NULL
otherwise	NULL
stated	NULL
)	NULL
,	NULL
giving	NULL
approximately	NULL
the	NULL
same	NULL
surface	NULL
area	NULL
as	NULL
50	NULL
x	NULL
10°/L	NULL
unactivated	NULL
or	NULL
calcium-ionophore-activated	NULL
platelets	NULL
.	NULL

Defibrinated	NULL
plasma	NULL
was	NULL
activated	NULL
with	NULL
Russel	NULL
's	NULL
Viper	NULL
Venom	NULL
,	NULL
and	NULL
the	NULL
thrombin	NULL
generated	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
platelets	NULL
or	NULL
apoptotic	NULL
VSMCs	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
chromogenic	NULL
assay	NULL
.	NULL

The	NULL
table	NULL
shows	NULL
the	NULL
area	NULL
under	NULL
the	NULL
thrombin	NULL
generation	NULL
curves	NULL
(	NULL
AUC	NULL
)	NULL
and	NULL
the	NULL
peak	NULL
thrombin	NULL
concentration	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
+	NULL
SEM	NULL
.	NULL

*	NULL
P	NULL
<	NULL
.005	NULL
compared	NULL
with	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
.	NULL

t	NULL
P	NULL
=	NULL
not	NULL
significant	NULL
compared	NULL
with	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
.	NULL

+P	NULL
<	NULL
.0001	NULL
compared	NULL
with	NULL
buffer	NULL
C.	NULL
by	NULL
apoptotic	NULL
VSMCs	NULL
was	NULL
dependent	NULL
on	NULL
exposure	NULL
of	NULL
phosphatidylserine	NULL
,	NULL
experiments	NULL
were	NULL
repeated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
annexin	NULL
V	NULL
,	NULL
a	NULL
specific	NULL
ligand	NULL
for	NULL
phosphatidylserine	NULL
with	NULL
a	NULL
kd	NULL
for	NULL
platelets	NULL
of	NULL
7	NULL
nmol/L	NULL
.	NULL
``	NULL

''	NULL
Apoptotic	NULL
VSMC-myc	NULL
cells	NULL
were	NULL
produced	NULL
and	NULL
harvested	NULL
as	NULL
before	NULL
and	NULL
resuspended	NULL
to	NULL
give	NULL
a	NULL
final	NULL
concentration	NULL
in	NULL
the	NULL
assay	NULL
of	NULL
2.24	NULL
x	NULL
10°/L	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
and	NULL
without	NULL
5	NULL
pmol/L	NULL
annexin	NULL
V	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
minutes	NULL
immediately	NULL
before	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
that	NULL
incubation	NULL
with	NULL
annexin	NULL
V	NULL
reduced	NULL
the	NULL
AUC	NULL
from	NULL
332.7	NULL
+	NULL
5.8	NULL
nmol	NULL
:	NULL
-	NULL
to	NULL
128.3	NULL
+	NULL
6.3	NULL
nmol	NULL
«	NULL
min	NULL
(	NULL
n	NULL
=	NULL
4	NULL
,	NULL
P	NULL
<	NULL
.0001	NULL
,	NULL
one-tailed	NULL
and	NULL
the	NULL
peak	NULL
thrombin	NULL
concentration	NULL
from	NULL
171.0	NULL
+	NULL
3.5	NULL
nmol/L	NULL
to	NULL
69.5	NULL
+	NULL
10.7	NULL
nmol/L	NULL
(	NULL
P	NULL
<	NULL
.0001	NULL
,	NULL
one-tailed	NULL
-test	NULL
)	NULL
.	NULL

Annexin	NULL
V	NULL
had	NULL
a	NULL
similar	NULL
effect	NULL
on	NULL
thrombin	NULL
generation	NULL
by	NULL
platelets	NULL
and	NULL
activated	NULL
platelets	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thrombin	NULL
generation	NULL
by	NULL
nonapoptotic	NULL
VSMC-myc	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
thrombin-generating	NULL
capacity	NULL
of	NULL
the	NULL
VSMC	NULL
cell	NULL
lines	NULL
studied	NULL
was	NULL
dependent	NULL
on	NULL
apoptosis	NULL
and	NULL
not	NULL
merely	NULL
a	NULL
property	NULL
of	NULL
transfected	NULL
VSMCs	NULL
,	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
was	NULL
adapted	NULL
to	NULL
study	NULL
nonapoptotic	NULL
VSMC-myc	NULL
cells	NULL
growing	NULL
in	NULL
monolayers	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Over	NULL
a	NULL
24-hour	NULL
period	NULL
,	NULL
the	NULL
rates	NULL
of	NULL
apoptosis	NULL
were	NULL
78.2	NULL
%	NULL
+	NULL
9.2	NULL
%	NULL
for	NULL
VSMC-myc	NULL
cells	NULL
in	NULL
0	NULL
%	NULL
FCS	NULL
and	NULL
4.6	NULL
%	NULL
+	NULL
0.7	NULL
%	NULL
for	NULL
those	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL
``	NULL

Figure	NULL
3	NULL
shows	NULL
that	NULL
the	NULL
VSMC-myc	NULL
cells	NULL
in	NULL
0	NULL
%	NULL
medium	NULL
generated	NULL
significantly	NULL
more	NULL
thrombin	NULL
than	NULL
the	NULL
VSMC-myc	NULL
cells	NULL
maintained	NULL
in	NULL
10	NULL
%	NULL
medium	NULL
,	NULL
with	NULL
an	NULL
AUC	NULL
of	NULL
209.3	NULL
+	NULL
19.0	NULL
nmol	NULL
<	NULL
min/L	NULL
(	NULL
n	NULL
=	NULL
6	NULL
)	NULL
and	NULL
87.3	NULL
+	NULL
10.0	NULL
nmol	NULL
-	NULL
min/L	NULL
(	NULL
n	NULL
=	NULL
6	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
P	NULL
=	NULL
.0002	NULL
,	NULL
one-tailed	NULL
#	NULL
test	NULL
)	NULL
.	NULL

Peak	NULL
thrombins	NULL
4381	NULL
were	NULL
93.9	NULL
+	NULL
9.8	NULL
nmol/L	NULL
and	NULL
39.6	NULL
+	NULL
4.2	NULL
nmol/L	NULL
,	NULL
respectively	NULL
(	NULL
P	NULL
=.0002	NULL
for	NULL
logarithmically	NULL
transformed	NULL
data	NULL
,	NULL
one-tailed	NULL
t-test	NULL
)	NULL
.	NULL

For	NULL
wells	NULL
with	NULL
no	NULL
coating	NULL
cells	NULL
,	NULL
the	NULL
AUC	NULL
was	NULL
55.9	NULL
+	NULL
1.0	NULL
nmol	NULL
+	NULL
min/L	NULL
and	NULL
the	NULL
peak	NULL
thrombin	NULL
was	NULL
25.1	NULL
+	NULL
0.8	NULL
nmol/L	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

These	NULL
values	NULL
were	NULL
less	NULL
than	NULL
those	NULL
for	NULL
VSMC-myc	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
(	NULL
P	NULL
=	NULL
.036	NULL
for	NULL
AUC	NULL
and	NULL
P	NULL
=	NULL
.028	NULL
for	NULL
peak	NULL
thrombin	NULL
,	NULL
two-tailed	NULL
#	NULL
test	NULL
assuming	NULL
unequal	NULL
variances	NULL
)	NULL
.	NULL

Thrombin	NULL
activation	NULL
is	NULL
thus	NULL
not	NULL
simply	NULL
an	NULL
intrinsic	NULL
property	NULL
of	NULL
the	NULL
transfected	NULL
VSMCs	NULL
;	NULL
apoptosis	NULL
is	NULL
also	NULL
required	NULL
.	NULL

Effect	NULL
of	NULL
serum	NULL
deprivation	NULL
on	NULL
thrombin	NULL
generation	NULL
.	NULL

To	NULL
show	NULL
that	NULL
removal	NULL
of	NULL
serum	NULL
itself	NULL
did	NULL
not	NULL
induce	NULL
phosphatidylserine	NULL
exposure	NULL
and	NULL
thrombin	NULL
generation	NULL
independently	NULL
of	NULL
apoptosis	NULL
,	NULL
we	NULL
induced	NULL
VSMC	NULL
apoptosis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
VSMCs	NULL
derived	NULL
from	NULL
atherosclerotic	NULL
human	NULL
coronary	NULL
plaques	NULL
undergo	NULL
a	NULL
high	NULL
rate	NULL
of	NULL
apoptosis	NULL
in	NULL
culture	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
.	NULL
``	NULL

We	NULL
therefore	NULL
studied	NULL
a	NULL
human	NULL
coronary	NULL
plaque	NULL
VSMC	NULL
line	NULL
expressing	NULL
adenovirus	NULL
E1A	NULL
(	NULL
HASMC-66	NULL
E1A	NULL
)	NULL
that	NULL
has	NULL
an	NULL
apoptotic	NULL
rate	NULL
of	NULL
7.11	NULL
%	NULL
+	NULL
0.8	NULL
%	NULL
over	NULL
24	NULL
hours	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
,	NULL
increasing	NULL
to	NULL
73.4	NULL
%	NULL
+	NULL
6.8	NULL
%	NULL
on	NULL
serum	NULL
withdrawal	NULL
(	NULL
M.R.B	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
that	NULL
human	NULL
plaque-derived	NULL
VSMCs	NULL
undergoing	NULL
apoptosis	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
generated	NULL
significantly	NULL
more	NULL
thrombin	NULL
than	NULL
buffer	NULL
C	NULL
alone	NULL
.	NULL

150	NULL
7	NULL
Thrombin	NULL
(	NULL
nmol/L	NULL
)	NULL
507	NULL
-	NULL
$	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fig	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
annexin	NULL
V	NULL
on	NULL
thrombin	NULL
generation	NULL
by	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
.	NULL

Apoptotic	NULL
VSMC-myc	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
resuspended	NULL
as	NULL
before	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
and	NULL
without	NULL
5	NULL
mol/L	NULL
annexin	NULL
V.	NULL
Thrombin	NULL
generation	NULL
curves	NULL
are	NULL
shown	NULL
for	NULL
apoptotic	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
)	NULL
and	NULL
annexin	NULL
V-treated	NULL
apoptotic	NULL
cells	NULL
(	NULL
¢	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4382	NULL
125	NULL
100	NULL
7	NULL
75	NULL
50	NULL
Thrombin	NULL
(	NULL
nmol/L	NULL
)	NULL
25	NULL
&	NULL
Ce	NULL
!	NULL

Time	NULL
(	NULL
min	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Thrombin	NULL
generation	NULL
by	NULL
monolayers	NULL
of	NULL
serum-starved	NULL
and	NULL
serum-maintained	NULL
VSMCs	NULL
.	NULL

VSMC-myc	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
monolayers	NULL
in	NULL
6-well	NULL
plates	NULL
.	NULL

Once	NULL
confluent	NULL
,	NULL
they	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
0	NULL
%	NULL
or	NULL
10	NULL
%	NULL
serum	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

After	NULL
a	NULL
second	NULL
washing	NULL
,	NULL
the	NULL
thrombin-generating	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
each	NULL
well	NULL
.	NULL

Curves	NULL
are	NULL
shown	NULL
for	NULL
0	NULL
%	NULL
serum	NULL
(	NULL
0	NULL
)	NULL
and	NULL
10	NULL
%	NULL
serum	NULL
(	NULL
¢	NULL
)	NULL
incubated	NULL
VSMCs	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cells	NULL
(	NULL
O	NULL
)	NULL
.	NULL

The	NULL
respective	NULL
AUCs	NULL
were	NULL
261.2	NULL
+	NULL
2.3	NULL
nmol	NULL
-min/L	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
and	NULL
43.8	NULL
+	NULL
3.4	NULL
nmol	NULL
-	NULL
min/L	NULL
(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
,	NULL
and	NULL
the	NULL
respective	NULL
peak	NULL
thrombins	NULL
were	NULL
128.0	NULL
+	NULL
3.5	NULL
nmol/L	NULL
and	NULL
26.3	NULL
+	NULL
2.5	NULL
nmol/L	NULL
(	NULL
P	NULL
<	NULL
.0001	NULL
for	NULL
logarithmically	NULL
transformed	NULL
AUC	NULL
and	NULL
peak	NULL
thrombin	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
values	NULL
for	NULL
the	NULL
bodies	NULL
generated	NULL
in	NULL
0	NULL
%	NULL
serum	NULL
were	NULL
303.1	NULL
+	NULL
26.1	NULL
nmol	NULL
«	NULL
min/L	NULL
and	NULL
158.8	NULL
+	NULL
18.6	NULL
nmol/L	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
which	NULL
were	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
bodies	NULL
generated	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
thrombin	NULL
generation	NULL
does	NULL
not	NULL
simply	NULL
result	NULL
from	NULL
serum	NULL
withdrawal	NULL
.	NULL

These	NULL
experiments	NULL
also	NULL
show	NULL
that	NULL
apoptotic	NULL
human	NULL
VSMCs	NULL
derived	NULL
from	NULL
coronary	NULL
artery	NULL
plaques	NULL
possess	NULL
a	NULL
significant	NULL
thrombin-generating	NULL
capacity	NULL
.	NULL

DISCUSSION	NULL
The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
VSMCs	NULL
undergoing	NULL
apoptosis	NULL
could	NULL
provide	NULL
a	NULL
surface	NULL
for	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
prothrombinase	NULL
complex	NULL
through	NULL
their	NULL
exposure	NULL
of	NULL
phosphatidylserine	NULL
.	NULL

We	NULL
studied	NULL
VSMC	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
rat	NULL
aortas	NULL
and	NULL
from	NULL
human	NULL
coronary	NULL
arteries	NULL
and	NULL
coronary	NULL
atherosclerotic	NULL
plaques	NULL
transfected	NULL
to	NULL
induce	NULL
stable	NULL
expression	NULL
of	NULL
pro-apoptotic	NULL
gene	NULL
products	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
reproducible	NULL
and	NULL
high	NULL
rates	NULL
of	NULL
apoptosis	NULL
can	NULL
be	NULL
in-duced	NULL
,	NULL
usually	NULL
by	NULL
the	NULL
withdrawal	NULL
of	NULL
serum	NULL
survival	NULL
factors	NULL
.	NULL

We	NULL
found	NULL
that	NULL
apoptotic	NULL
bodies	NULL
derived	NULL
from	NULL
rat	NULL
VSMC-myc	NULL
cells	NULL
by	NULL
serum	NULL
withdrawal	NULL
generated	NULL
active	NULL
thrombin	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
cleavage	NULL
of	NULL
$	NULL
2238	NULL
and	NULL
inhibited	NULL
by	NULL
hirudin	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
amount	NULL
of	NULL
thrombin	NULL
generated	NULL
by	NULL
apoptotic	NULL
bodies	NULL
was	NULL
physiologically	NULL
relevant	NULL
,	NULL
platelets	NULL
and	NULL
FLYNN	NULL
ET	NULL
AL	NULL
calcium	NULL
ionophore-activated	NULL
platelets	NULL
were	NULL
also	NULL
studied	NULL
.	NULL

Activation	NULL
of	NULL
platelets	NULL
is	NULL
known	NULL
to	NULL
result	NULL
in	NULL
phosphatidylserine	NULL
exposure	NULL
:	NULL
collagen	NULL
and	NULL
thrombin	NULL
together	NULL
cause	NULL
the	NULL
exposure	NULL
of	NULL
100,000	NULL
sites	NULL
per	NULL
platelet	NULL
,	NULL
and	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
causes	NULL
the	NULL
exposure	NULL
of	NULL
200,000	NULL
sites	NULL
per	NULL
platelet	NULL
as	NULL
measured	NULL
by	NULL
annexin	NULL
V	NULL
binding	NULL
.	NULL
``	NULL

''	NULL
Because	NULL
platelets	NULL
and	NULL
apoptotic	NULL
bodies	NULL
differ	NULL
in	NULL
size	NULL
,	NULL
the	NULL
concentrations	NULL
used	NULL
in	NULL
the	NULL
assay	NULL
were	NULL
adjusted	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
equate	NULL
the	NULL
total	NULL
surface	NULL
area	NULL
present	NULL
.	NULL

Given	NULL
that	NULL
platelet	NULL
activation	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
surface	NULL
microparticles	NULL
that	NULL
may	NULL
be	NULL
the	NULL
major	NULL
site	NULL
of	NULL
phosphatidylserine	NULL
exposure	NULL
and	NULL
the	NULL
assumptions	NULL
underlying	NULL
the	NULL
calculations	NULL
,	NULL
this	NULL
must	NULL
be	NULL
regarded	NULL
as	NULL
an	NULL
approximation	NULL
at	NULL
best	NULL
.	NULL

We	NULL
found	NULL
that	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
generated	NULL
significantly	NULL
more	NULL
thrombin	NULL
than	NULL
unactivated	NULL
platelets	NULL
and	NULL
a	NULL
similar	NULL
amount	NULL
to	NULL
platelets	NULL
maximally	NULL
activated	NULL
by	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
the	NULL
concentration	NULL
of	NULL
apoptotic	NULL
VSMCs	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
thrombin	NULL
generated	NULL
further	NULL
suggests	NULL
that	NULL
the	NULL
thrombin	NULL
generation	NULL
resulted	NULL
from	NULL
a	NULL
specific	NULL
property	NULL
of	NULL
the	NULL
apoptotic	NULL
cell	NULL
membrane	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
apoptotic	NULL
human	NULL
VSMCs	NULL
expressing	NULL
E1A	NULL
also	NULL
had	NULL
a	NULL
significant	NULL
thrombin-generating	NULL
capacity	NULL
,	NULL
although	NULL
Thrombin	NULL
(	NULL
amoL	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Thrombin	NULL
generation	NULL
by	NULL
apoptotic	NULL
VSMCs	NULL
generated	NULL
in	NULL
0	NULL
%	NULL
and	NULL
10	NULL
%	NULL
serum	NULL
.	NULL

VSMCs	NULL
derived	NULL
from	NULL
human	NULL
coronary	NULL
atherosclerotic	NULL
plaques	NULL
(	NULL
HASMC-66	NULL
E1A	NULL
)	NULL
,	NULL
which	NULL
apoptose	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
,	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
.	NULL

Thrombin	NULL
generation	NULL
was	NULL
measured	NULL
for	NULL
apoptotic	NULL
HASMC-66	NULL
ETA	NULL
cells	NULL
generated	NULL
in	NULL
0	NULL
%	NULL
(	NULL
0	NULL
)	NULL
and	NULL
10	NULL
%	NULL
(	NULL
¢	NULL
)	NULL
serum	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
the	NULL
thrombin-generation	NULL
curve	NULL
for	NULL
buffer	NULL
C	NULL
is	NULL
also	NULL
shown	NULL
(	NULL
O	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

THROMBIN	NULL
GENERATION	NULL
BY	NULL
APOPTOTIC	NULL
VSMCs	NULL
less	NULL
than	NULL
that	NULL
of	NULL
rat	NULL
VSMC-myc	NULL
cells	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
number	NULL
of	NULL
exposed	NULL
phosphatidylserine	NULL
sites	NULL
,	NULL
because	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
apoptotic	NULL
rat	NULL
VSMC-myc	NULL
cells	NULL
express	NULL
twice	NULL
as	NULL
many	NULL
annexin	NULL
V	NULL
binding	NULL
sites	NULL
as	NULL
apoptotic	NULL
VSMCs	NULL
expressing	NULL
E1A	NULL
.	NULL

``	NULL
°	NULL
The	NULL
reason	NULL
for	NULL
this	NULL
difference	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
but	NULL
may	NULL
reflect	NULL
differing	NULL
potencies	NULL
of	NULL
the	NULL
pro-apoptotic	NULL
gene	NULL
products	NULL
,	NULL
just	NULL
as	NULL
the	NULL
variation	NULL
in	NULL
the	NULL
procoagulant	NULL
potency	NULL
of	NULL
different	NULL
platelet	NULL
agonists	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
from	NULL
a	NULL
difference	NULL
in	NULL
phosphatidylserine	NULL
ex-posure	NULL
.	NULL
``	NULL

We	NULL
showed	NULL
that	NULL
phosphatidylserine	NULL
exposure	NULL
was	NULL
required	NULL
for	NULL
thrombin	NULL
generation	NULL
as	NULL
annexin	NULL
V	NULL
,	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
very	NULL
high	NULL
affinity	NULL
for	NULL
phosphatidylserine	NULL
at	NULL
physio-logic	NULL
calcium	NULL
concentrations	NULL
,	NULL
significantly	NULL
reduced	NULL
thrombin	NULL
generation	NULL
by	NULL
apoptotic	NULL
VSMCs	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
apoptosis	NULL
was	NULL
necessary	NULL
for	NULL
the	NULL
thrombin-generating	NULL
capacity	NULL
of	NULL
apoptotic	NULL
VSMC-myc	NULL
cells	NULL
and	NULL
that	NULL
it	NULL
was	NULL
not	NULL
just	NULL
an	NULL
intrinsic	NULL
feature	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
required	NULL
the	NULL
modification	NULL
of	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
for	NULL
use	NULL
with	NULL
monolayers	NULL
.	NULL

The	NULL
adapted	NULL
assay	NULL
allowed	NULL
the	NULL
comparison	NULL
of	NULL
thrombin	NULL
activation	NULL
by	NULL
monolayers	NULL
with	NULL
different	NULL
rates	NULL
of	NULL
apoptosis	NULL
.	NULL

Serum-starved	NULL
VSMC-myc	NULL
cells	NULL
generated	NULL
significantly	NULL
more	NULL
thrombin	NULL
than	NULL
cells	NULL
maintained	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
.	NULL

There	NULL
was	NULL
a	NULL
small	NULL
difference	NULL
between	NULL
the	NULL
latter	NULL
and	NULL
the	NULL
nonspecific	NULL
reaction	NULL
that	NULL
occurred	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
cells	NULL
.	NULL

The	NULL
relative	NULL
contribution	NULL
to	NULL
this	NULL
of	NULL
the	NULL
nonapoptotic	NULL
VSMC-myc	NULL
cells	NULL
and	NULL
of	NULL
the	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
that	NULL
undergo	NULL
apoptosis	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
is	NULL
not	NULL
known	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
there	NULL
was	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
thrombin-generating	NULL
capacity	NULL
after	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
serum	NULL
withdrawal	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
significant	NULL
thrombin	NULL
production	NULL
by	NULL
apoptotic	NULL
human	NULL
coronary	NULL
plaque	NULL
VSMCs	NULL
produced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
,	NULL
thereby	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
serum	NULL
contains	NULL
some	NULL
factor	NULL
that	NULL
inhibits	NULL
cell-associated	NULL
thrombin	NULL
generation	NULL
on	NULL
cells	NULL
and	NULL
that	NULL
serum	NULL
withdrawal	NULL
per	NULL
se	NULL
accounts	NULL
for	NULL
our	NULL
results	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
experiments	NULL
show	NULL
that	NULL
VSMCs	NULL
possess	NULL
a	NULL
significant	NULL
thrombin-generating	NULL
capacity	NULL
when	NULL
they	NULL
undergo	NULL
apoptosis	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
direct	NULL
demonstration	NULL
of	NULL
thrombin	NULL
activation	NULL
by	NULL
apoptotic	NULL
cells	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
study	NULL
that	NULL
showed	NULL
a	NULL
decreased	NULL
clotting	NULL
time	NULL
in	NULL
plasma	NULL
exposed	NULL
to	NULL
irradiated	NULL
endothelial	NULL
cells	NULL
,	NULL
nutrient-deprived	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
a	NULL
temperature-sensitive	NULL
murine	NULL
lymphocyte	NULL
cell	NULL
line	NULL
undergoing	NULL
apoptosis	NULL
.	NULL
``	NULL

This	NULL
effect	NULL
was	NULL
abolished	NULL
by	NULL
annexin	NULL
V	NULL
and	NULL
so	NULL
was	NULL
also	NULL
phosphatidylserine-dependent	NULL
.	NULL

Thrombin	NULL
generation	NULL
was	NULL
not	NULL
measured	NULL
,	NULL
but	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
it	NULL
was	NULL
thrombin	NULL
production	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
apoptotic	NULL
cells	NULL
that	NULL
induced	NULL
clot	NULL
formation	NULL
.	NULL

Ultrastructural	NULL
study	NULL
showed	NULL
binding	NULL
of	NULL
the	NULL
annexin	NULL
V	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
but	NULL
not	NULL
to	NULL
internal	NULL
cellular	NULL
membranes	NULL
,	NULL
showing	NULL
that	NULL
thrombin	NULL
generation	NULL
does	NULL
not	NULL
result	NULL
from	NULL
a	NULL
loss	NULL
of	NULL
membrane	NULL
integrity	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
prothrombinase	NULL
complex	NULL
on	NULL
the	NULL
internal	NULL
plasma	NULL
membrane	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
showed	NULL
exclusion	NULL
of	NULL
trypan	NULL
blue	NULL
by	NULL
all	NULL
the	NULL
apoptotic	NULL
cells	NULL
that	NULL
were	NULL
studied	NULL
in	NULL
the	NULL
thrombin	NULL
generation	NULL
assay	NULL
.	NULL

These	NULL
data	NULL
do	NULL
suggest	NULL
that	NULL
all	NULL
apoptotic	NULL
cells	NULL
may	NULL
have	NULL
a	NULL
thrombin-generating	NULL
capacity	NULL
by	NULL
virtue	NULL
of	NULL
phosphatidylserine	NULL
exposure	NULL
.	NULL

Classically	NULL
,	NULL
apoptosis	NULL
has	NULL
been	NULL
viewed	NULL
as	NULL
a	NULL
mechanism	NULL
of	NULL
silent	NULL
cell	NULL
removal	NULL
without	NULL
signaling	NULL
sequelae	NULL
.	NULL

However	NULL
,	NULL
the	NULL
experiments	NULL
described	NULL
here	NULL
suggest	NULL
4383	NULL
that	NULL
apoptotic	NULL
VSMCs	NULL
could	NULL
provide	NULL
a	NULL
site	NULL
for	NULL
the	NULL
local	NULL
generation	NULL
of	NULL
thrombin	NULL
.	NULL

The	NULL
most	NULL
obvious	NULL
site	NULL
in	NULL
the	NULL
vasculature	NULL
for	NULL
thrombin	NULL
generation	NULL
dependent	NULL
on	NULL
apoptosis	NULL
is	NULL
the	NULL
atherosclerotic	NULL
plaque	NULL
.	NULL

Tissue	NULL
factor	NULL
activity	NULL
has	NULL
been	NULL
documented	NULL
in	NULL
plaques	NULL
,	NULL
``	NULL
is	NULL
expressed	NULL
by	NULL
plaque	NULL
VSMCs	NULL
,	NULL
``	NULL
and	NULL
could	NULL
allow	NULL
the	NULL
activation	NULL
of	NULL
factor	NULL
X	NULL
and	NULL
subsequent	NULL
thrombin	NULL
generation	NULL
on	NULL
an	NULL
anionic	NULL
phospholipid	NULL
surface	NULL
.	NULL

Although	NULL
a	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
shown	NULL
the	NULL
presence	NULL
of	NULL
apoptotic	NULL
VSMCs	NULL
in	NULL
plaques	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
current	NULL
methodologies	NULL
do	NULL
not	NULL
allow	NULL
an	NULL
accurate	NULL
quantitation	NULL
of	NULL
their	NULL
frequency	NULL
,	NULL
so	NULL
it	NULL
is	NULL
not	NULL
possible	NULL
to	NULL
extrapolate	NULL
directly	NULL
from	NULL
our	NULL
data	NULL
to	NULL
the	NULL
situation	NULL
in	NULL
the	NULL
arterial	NULL
wall	NULL
.	NULL

Nonetheless	NULL
,	NULL
VSMCs	NULL
derived	NULL
from	NULL
atherosclerotic	NULL
plaques	NULL
maintain	NULL
a	NULL
high	NULL
rate	NULL
of	NULL
apoptosis	NULL
in	NULL
culture	NULL
``	NULL
``	NULL
and	NULL
it	NULL
may	NULL
be	NULL
relevant	NULL
that	NULL
we	NULL
have	NULL
shown	NULL
significant	NULL
thrombin	NULL
generation	NULL
in	NULL
these	NULL
VSMCs	NULL
.	NULL

Our	NULL
data	NULL
allow	NULL
speculation	NULL
that	NULL
apoptosing	NULL
VSMCs	NULL
provide	NULL
a	NULL
catalytic	NULL
surface	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
thrombin	NULL
within	NULL
the	NULL
atherosclerotic	NULL
plaque	NULL
.	NULL

This	NULL
could	NULL
in	NULL
turn	NULL
contribute	NULL
to	NULL
the	NULL
deposition	NULL
of	NULL
fibrin	NULL
seen	NULL
in	NULL
plaques	NULL
,	NULL
``	NULL
although	NULL
the	NULL
classical	NULL
view	NULL
has	NULL
been	NULL
that	NULL
this	NULL
results	NULL
from	NULL
the	NULL
incorporation	NULL
of	NULL
mural	NULL
thrombi	NULL
into	NULL
the	NULL
plaque	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
very	NULL
phosphatidylserine	NULL
exposure	NULL
that	NULL
allows	NULL
thrombin	NULL
generation	NULL
may	NULL
also	NULL
mediate	NULL
the	NULL
recognition	NULL
and	NULL
phagocytosis	NULL
of	NULL
apoptotic	NULL
VSMCs	NULL
by	NULL
other	NULL
VSMCs	NULL
,	NULL
therefore	NULL
removing	NULL
exposed	NULL
phosphatidylserine	NULL
and	NULL
limiting	NULL
thrombin	NULL
production	NULL
.	NULL
``	NULL

''	NULL
Further	NULL
work	NULL
will	NULL
be	NULL
required	NULL
to	NULL
determine	NULL
whether	NULL
apoptotic	NULL
cells	NULL
in	NULL
plaques	NULL
do	NULL
indeed	NULL
provide	NULL
a	NULL
catalytic	NULL
site	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
thrombin	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Davey	NULL
MG	NULL
,	NULL
Luscher	NULL
EF	NULL
:	NULL
Actions	NULL
of	NULL
thrombin	NULL
and	NULL
other	NULL
coagulant	NULL
and	NULL
proteolytic	NULL
enzymes	NULL
on	NULL
blood	NULL
platelets	NULL
.	NULL

Nature	NULL
216:857	NULL
,	NULL
1967	NULL
2	NULL
.	NULL

McNamara	NULL
CA	NULL
,	NULL
Sarembock	NULL
IJ	NULL
,	NULL
Gimple	NULL
LW	NULL
,	NULL
Fenton	NULL
JW	NULL
II	NULL
,	NULL
Coughlin	NULL
SR	NULL
,	NULL
Owens	NULL
GK	NULL
:	NULL
Thrombin	NULL
stimulates	NULL
proliferation	NULL
of	NULL
cultured	NULL
rat	NULL
aortic	NULL
smooth	NULL
muscle	NULL
cells	NULL
by	NULL
a	NULL
proteolytically	NULL
activated	NULL
receptor	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91:94	NULL
,	NULL
1993	NULL
3	NULL
.	NULL

Herbert	NULL
JM	NULL
,	NULL
Lamarche	NULL
I	NULL
,	NULL
Dol	NULL
F	NULL
:	NULL
Induction	NULL
of	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cell	NULL
growth	NULL
by	NULL
selective	NULL
activation	NULL
of	NULL
the	NULL
thrombin	NULL
receptor	NULL
.	NULL

FEBS	NULL
Lett	NULL
301:155	NULL
,	NULL
1992	NULL
4	NULL
.	NULL

Noda-Heiny	NULL
H	NULL
,	NULL
Sobel	NULL
BE	NULL
:	NULL
Vascular	NULL
smooth	NULL
muscle	NULL
cell	NULL
migration	NULL
mediated	NULL
by	NULL
thrombin	NULL
and	NULL
urokinase	NULL
receptor	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
268	NULL
:	NULL
C1195	NULL
,	NULL
1995	NULL
5	NULL
.	NULL

Woijta	NULL
J	NULL
,	NULL
Gallicchio	NULL
M	NULL
,	NULL
Zoellner	NULL
H	NULL
,	NULL
Hufnagl	NULL
P	NULL
,	NULL
Last	NULL
K	NULL
,	NULL
Filonzi	NULL
EL	NULL
,	NULL
Binder	NULL
BR	NULL
,	NULL
Hamilton	NULL
JA	NULL
,	NULL
McGrath	NULL
K	NULL
:	NULL
Thrombin	NULL
stimulates	NULL
expression	NULL
of	NULL
tissue-type	NULL
plasminogen	NULL
activator	NULL
and	NULL
plasminogen	NULL
activator	NULL
inhibitor	NULL
type	NULL
I	NULL
in	NULL
cultured	NULL
human	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Thromb	NULL
Haemost	NULL
70:469	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Hattori	NULL
R	NULL
,	NULL
Hamilton	NULL
KK	NULL
,	NULL
Fugate	NULL
RD	NULL
,	NULL
McEver	NULL
RP	NULL
,	NULL
Sims	NULL
PJ	NULL
:	NULL
Stimulated	NULL
secretion	NULL
of	NULL
endothelial	NULL
vWF	NULL
is	NULL
accompanied	NULL
by	NULL
rapid	NULL
redistribution	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
the	NULL
intracellular	NULL
granule	NULL
membrane	NULL
protein	NULL
GMP-140	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:7768	NULL
,	NULL
1989	NULL
7	NULL
.	NULL

Laposata	NULL
M	NULL
,	NULL
Dovnorsky	NULL
DK	NULL
,	NULL
Solkin	NULL
HS	NULL
:	NULL
Thrombin	NULL
induced	NULL
gap	NULL
formation	NULL
in	NULL
confluent	NULL
endothelial	NULL
cell	NULL
monolayers	NULL
in	NULL
vitro	NULL
.	NULL

Blood	NULL
62:549	NULL
,	NULL
1983	NULL
8	NULL
.	NULL

Wenzel	NULL
UO	NULL
,	NULL
Fouqueray	NULL
B	NULL
,	NULL
Grandaliano	NULL
G	NULL
,	NULL
Kim	NULL
Y-8	NULL
,	NULL
Kara-mitsos	NULL
C	NULL
,	NULL
Valente	NULL
AJ	NULL
,	NULL
Abboud	NULL
HE	NULL
:	NULL
Thrombin	NULL
regulates	NULL
expression	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Circ	NULL
Res	NULL
77:503	NULL
,	NULL
1995	NULL
9	NULL
.	NULL

Bar-Shavit	NULL
R	NULL
,	NULL
Kahn	NULL
A	NULL
,	NULL
Fenton	NULL
JW	NULL
II	NULL
,	NULL
Wilner	NULL
GD	NULL
:	NULL
Chemotactic	NULL
response	NULL
of	NULL
monocytes	NULL
to	NULL
thrombin	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
96:282	NULL
,	NULL
1983	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4384	NULL
10	NULL
.	NULL

Gelehrter	NULL
TD	NULL
,	NULL
Sznycer-Laszyk	NULL
R	NULL
:	NULL
Thrombin	NULL
induction	NULL
of	NULL
plasminogen	NULL
activator	NULL
inhibitor	NULL
in	NULL
cultured	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
77:165	NULL
,	NULL
1986	NULL
11	NULL
.	NULL

Kohno	NULL
M	NULL
,	NULL
Yasunari	NULL
K	NULL
,	NULL
Yokokawa	NULL
K	NULL
,	NULL
Mirakawa	NULL
K	NULL
,	NULL
Morio	NULL
T	NULL
,	NULL
Kanayama	NULL
Y	NULL
,	NULL
Fuzisawa	NULL
M	NULL
,	NULL
Inone	NULL
T	NULL
,	NULL
Takeda	NULL
T	NULL
:	NULL
Thrombin	NULL
stimulates	NULL
the	NULL
production	NULL
of	NULL
immunoreactive	NULL
endothelin-1	NULL
in	NULL
cultured	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
.	NULL

Metabolism	NULL
39:1003	NULL
,	NULL
1990	NULL
12	NULL
.	NULL

Nelken	NULL
NA	NULL
,	NULL
Soifer	NULL
SJ	NULL
,	NULL
O'Keefe	NULL
J	NULL
,	NULL
Vu	NULL
T-KH	NULL
,	NULL
Charo	NULL
IF	NULL
,	NULL
Coughlin	NULL
SR	NULL
:	NULL
Thrombin	NULL
receptor	NULL
expression	NULL
in	NULL
normal	NULL
and	NULL
atherosclerotic	NULL
human	NULL
arteries	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
90:1614	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Wilcox	NULL
JN	NULL
,	NULL
Rodriguez	NULL
J	NULL
,	NULL
Subramanian	NULL
R	NULL
,	NULL
Ollerenshaw	NULL
J	NULL
,	NULL
Zhang	NULL
CZ	NULL
,	NULL
Hayzer	NULL
DJ	NULL
,	NULL
Horaist	NULL
C	NULL
,	NULL
Hanson	NULL
SR	NULL
,	NULL
Lumsden	NULL
A	NULL
,	NULL
Salam	NULL
TA	NULL
,	NULL
Kelly	NULL
AB	NULL
,	NULL
Harker	NULL
LA	NULL
,	NULL
Runge	NULL
M	NULL
:	NULL
Characterisation	NULL
of	NULL
thrombin	NULL
receptor	NULL
expression	NULL
during	NULL
vascular	NULL
lesion	NULL
formation	NULL
.	NULL

Cire	NULL
Res	NULL
75:1029	NULL
,	NULL
1994	NULL
14.	NULL
von	NULL
Rokitansky	NULL
CF	NULL
:	NULL
A	NULL
Manual	NULL
of	NULL
Pathological	NULL
Anatomy	NULL
(	NULL
1852	NULL
)	NULL
(	NULL
translated	NULL
by	NULL
Day	NULL
GE	NULL
)	NULL
,	NULL
vol	NULL
4	NULL
.	NULL

London	NULL
,	NULL
UK	NULL
,	NULL
Sydenham	NULL
Soci-ety	NULL
,	NULL
p	NULL
261	NULL
15	NULL
.	NULL

Nolf	NULL
P	NULL
:	NULL
Contribution	NULL
a	NULL
I	NULL
'	NULL
étude	NULL
de	NULL
la	NULL
coagulation	NULL
du	NULL
sang	NULL
(	NULL
5°°	NULL
memoire	NULL
)	NULL
;	NULL
la	NULL
fibrolyse	NULL
.	NULL

Arch	NULL
Int	NULL
Physiol	NULL
6:306	NULL
,	NULL
1908	NULL
16	NULL
.	NULL

Bevers	NULL
EM	NULL
,	NULL
Rosing	NULL
J	NULL
,	NULL
Zwaal	NULL
RFA	NULL
:	NULL
Platelets	NULL
and	NULL
coagulation	NULL
,	NULL
in	NULL
MacIntyre	NULL
DE	NULL
,	NULL
Gordon	NULL
JL	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Platelets	NULL
in	NULL
Biology	NULL
and	NULL
Pathol-ogy	NULL
,	NULL
vol	NULL
3	NULL
.	NULL

Research	NULL
Monograms	NULL
in	NULL
Cellular	NULL
Tissue	NULL
and	NULL
Physiology	NULL
,	NULL
vol	NULL
13	NULL
.	NULL

Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
,	NULL
Elsevier	NULL
,	NULL
1987	NULL
,	NULL
p	NULL
127	NULL
17	NULL
.	NULL

Bevers	NULL
EM	NULL
,	NULL
Comfurius	NULL
P	NULL
,	NULL
Zwaal	NULL
RFA	NULL
:	NULL
Platelet	NULL
procoagulant	NULL
activity	NULL
:	NULL
Physiological	NULL
significance	NULL
and	NULL
mechanisms	NULL
of	NULL
exposure	NULL
.	NULL

Blood	NULL
Rev	NULL
5:146	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Sims	NULL
PJ	NULL
,	NULL
Wiedmer	NULL
T	NULL
,	NULL
Esmon	NULL
CT	NULL
,	NULL
Weiss	NULL
HJ	NULL
,	NULL
Shattil	NULL
SJ	NULL
:	NULL
Assembly	NULL
of	NULL
the	NULL
platelet	NULL
prothrombinase	NULL
complex	NULL
is	NULL
linked	NULL
to	NULL
vesicula-tion	NULL
of	NULL
the	NULL
platelet	NULL
plasma	NULL
membrane	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:17049	NULL
,	NULL
1989	NULL
19	NULL
.	NULL

Sims	NULL
PJ	NULL
,	NULL
Faioni	NULL
EM	NULL
,	NULL
Wiedmer	NULL
T	NULL
,	NULL
Shattil	NULL
SJ	NULL
:	NULL
Complement	NULL
proteins	NULL
C5B-9	NULL
cause	NULL
release	NULL
of	NULL
membrane	NULL
vesicles	NULL
from	NULL
the	NULL
platelet	NULL
surface	NULL
that	NULL
are	NULL
enriched	NULL
in	NULL
the	NULL
membrane	NULL
receptor	NULL
for	NULL
coagulation	NULL
factor	NULL
Va	NULL
and	NULL
express	NULL
prothrombinase	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
263:18205	NULL
,	NULL
1988	NULL
20	NULL
.	NULL

Rosing	NULL
J	NULL
,	NULL
Van	NULL
Rijn	NULL
JLML	NULL
,	NULL
Bevers	NULL
EM	NULL
,	NULL
Van	NULL
Dicijen	NULL
G	NULL
,	NULL
Comfurius	NULL
P	NULL
,	NULL
Zwaal	NULL
RFA	NULL
:	NULL
The	NULL
role	NULL
of	NULL
activated	NULL
human	NULL
platelets	NULL
in	NULL
prothrombin	NULL
and	NULL
factor	NULL
X	NULL
activation	NULL
.	NULL

Blood	NULL
65:319	NULL
,	NULL
1985	NULL
21	NULL
.	NULL

Bevers	NULL
EM	NULL
,	NULL
Comfurius	NULL
P	NULL
,	NULL
Zwaal	NULL
RFA	NULL
:	NULL
The	NULL
nature	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
prothrombinase	NULL
at	NULL
the	NULL
platelet	NULL
surface	NULL
as	NULL
revealed	NULL
by	NULL
lipolytic	NULL
enzymes	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
122:81	NULL
,	NULL
1982	NULL
22	NULL
.	NULL

Van	NULL
Dicijen	NULL
G	NULL
,	NULL
Tans	NULL
G	NULL
,	NULL
Rosing	NULL
J	NULL
,	NULL
Hemker	NULL
HC	NULL
:	NULL
The	NULL
role	NULL
of	NULL
phospholipid	NULL
and	NULL
factor	NULL
VIIa	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
bovine	NULL
factor	NULL
X.	NULL
J	NULL
Biol	NULL
Chem	NULL
256:3422	NULL
,	NULL
1981	NULL
23	NULL
.	NULL

Van	NULL
Rijn	NULL
JLML	NULL
,	NULL
Govers-Riemslag	NULL
JWP	NULL
,	NULL
Zwaal	NULL
RFA	NULL
,	NULL
Rosing	NULL
J	NULL
:	NULL
Kinetic	NULL
studies	NULL
of	NULL
prothrombin	NULL
activation-Effect	NULL
of	NULL
factor	NULL
Va	NULL
and	NULL
phospholipids	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
enzyme	NULL
substrate	NULL
complex	NULL
.	NULL

Biochemistry	NULL
23:4557	NULL
,	NULL
1984	NULL
24	NULL
.	NULL

Thiagarajan	NULL
P	NULL
,	NULL
Tait	NULL
JF	NULL
:	NULL
Collagen-induced	NULL
exposure	NULL
of	NULL
anionic	NULL
phospholipids	NULL
in	NULL
platelets	NULL
and	NULL
platelet-derived	NULL
microparticles	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:24302	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Fadok	NULL
VA	NULL
,	NULL
Voelker	NULL
DR	NULL
,	NULL
Campbell	NULL
PA	NULL
,	NULL
Cohen	NULL
JJ	NULL
,	NULL
Bratton	NULL
FLYNN	NULL
ET	NULL
AL	NULL
DL	NULL
,	NULL
Henson	NULL
PM	NULL
:	NULL
Exposure	NULL
of	NULL
phosphatidylserine	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
apoptotic	NULL
lymphocytes	NULL
triggers	NULL
specific	NULL
recognition	NULL
and	NULL
removal	NULL
by	NULL
macrophages	NULL
.	NULL

J	NULL
Immunol	NULL
148:2207	NULL
,	NULL
1992	NULL
26	NULL
.	NULL

Bennett	NULL
MR	NULL
,	NULL
Evan	NULL
GI	NULL
,	NULL
Newby	NULL
AC	NULL
:	NULL
Deregulated	NULL
expression	NULL
of	NULL
the	NULL
c-myc	NULL
oncogene	NULL
abolishes	NULL
inhibition	NULL
of	NULL
proliferation	NULL
of	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
by	NULL
serum	NULL
reduction	NULL
,	NULL
interferon-y	NULL
,	NULL
hepa-rin	NULL
and	NULL
cyclic	NULL
nucleotide	NULL
analogues	NULL
and	NULL
induces	NULL
apoptosis	NULL
.	NULL

Circ	NULL
Res	NULL
74:525	NULL
,	NULL
1994	NULL
27	NULL
.	NULL

Bennett	NULL
MR	NULL
,	NULL
Evan	NULL
GI	NULL
,	NULL
Schwartz	NULL
SM	NULL
:	NULL
Apoptosis	NULL
of	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
p53-dependent	NULL
and	NULL
-indepen-dent	NULL
pathways	NULL
.	NULL

Circ	NULL
Res	NULL
77:266	NULL
,	NULL
1995	NULL
28	NULL
.	NULL

Bennett	NULL
MR	NULL
,	NULL
Gibson	NULL
DF	NULL
,	NULL
Schwartz	NULL
SM	NULL
,	NULL
Tait	NULL
JF	NULL
:	NULL
Binding	NULL
and	NULL
phagocytosis	NULL
of	NULL
apoptotic	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
is	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
exposure	NULL
of	NULL
phosphatidylserine	NULL
.	NULL

Circ	NULL
Res	NULL
77:1136	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Geng	NULL
Y	NULL
,	NULL
Libby	NULL
P	NULL
:	NULL
Evidence	NULL
for	NULL
apoptosis	NULL
in	NULL
advanced	NULL
human	NULL
atheroma	NULL
:	NULL
Colocalization	NULL
with	NULL
converting	NULL
enzyme	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:251	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Han	NULL
DKM	NULL
,	NULL
Haudenschild	NULL
CC	NULL
,	NULL
Hong	NULL
MK	NULL
,	NULL
Tinkle	NULL
BT	NULL
,	NULL
Leon	NULL
MB	NULL
,	NULL
Liau	NULL
G	NULL
:	NULL
Evidence	NULL
for	NULL
apoptosis	NULL
in	NULL
human	NULL
atherosclerosis	NULL
and	NULL
in	NULL
rat	NULL
vascular	NULL
injury	NULL
model	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:267	NULL
,	NULL
1995	NULL
31	NULL
.	NULL

Bennett	NULL
MR	NULL
,	NULL
Evan	NULL
GI	NULL
,	NULL
Schwartz	NULL
SM	NULL
:	NULL
Apoptosis	NULL
of	NULL
human	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
derived	NULL
from	NULL
normal	NULL
vessels	NULL
and	NULL
coronary	NULL
atherosclerotic	NULL
plaques	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
95:2266	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Morgenstern	NULL
J	NULL
,	NULL
Land	NULL
H	NULL
:	NULL
Choice	NULL
and	NULL
manipulation	NULL
of	NULL
retroviral	NULL
vectors	NULL
,	NULL
in	NULL
Murray	NULL
EJ	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Gene	NULL
Transfer	NULL
and	NULL
Expression	NULL
Protocols	NULL
.	NULL

Clifton	NULL
,	NULL
NJ	NULL
,	NULL
Humana	NULL
,	NULL
1991	NULL
,	NULL
p	NULL
181	NULL
33	NULL
.	NULL

Hemker	NULL
H	NULL
,	NULL
Beguin	NULL
S	NULL
:	NULL
How	NULL
to	NULL
measure	NULL
the	NULL
relevant	NULL
effect	NULL
of	NULL
anticoagulant	NULL
treatment	NULL
on	NULL
the	NULL
coagulability	NULL
of	NULL
plasma	NULL
,	NULL
in	NULL
Poller	NULL
L	NULL
,	NULL
Thomson	NULL
JM	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Thrombosis	NULL
and	NULL
Its	NULL
Management	NULL
.	NULL

Edinburgh	NULL
,	NULL
UK	NULL
,	NULL
Churchill	NULL
Livingstone	NULL
,	NULL
1993	NULL
,	NULL
p	NULL
3	NULL
34	NULL
.	NULL

Lee	NULL
L-H	NULL
,	NULL
Baglin	NULL
TP	NULL
:	NULL
Altered	NULL
platelet	NULL
phospholipid-dependent	NULL
thrombin	NULL
generation	NULL
in	NULL
thrombocytopaenia	NULL
and	NULL
thrombocytosis	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
89:131	NULL
,	NULL
1995	NULL
35	NULL
.	NULL

Rota	NULL
S	NULL
,	NULL
Flynn	NULL
PD	NULL
,	NULL
Wareham	NULL
NJ	NULL
,	NULL
Baglin	NULL
TP	NULL
,	NULL
Byme	NULL
CD	NULL
:	NULL
Is	NULL
platelet	NULL
phospholipid-dependent	NULL
thrombin	NULL
generation	NULL
altered	NULL
by	NULL
acute	NULL
myocardial	NULL
infarction	NULL
or	NULL
aspirin	NULL
?	NULL

Thromb	NULL
Res	NULL
83:329	NULL
,	NULL
1996	NULL
36	NULL
.	NULL

Thiagarajan	NULL
P	NULL
,	NULL
Tait	NULL
JF	NULL
:	NULL
Binding	NULL
of	NULL
annexin	NULL
V/placental	NULL
anticoagulant	NULL
protein	NULL
I	NULL
to	NULL
platelets	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:17420	NULL
,	NULL
1990	NULL
37	NULL
.	NULL

Bevers	NULL
EM	NULL
,	NULL
Comfurius	NULL
P	NULL
,	NULL
Zwaal	NULL
RFA	NULL
:	NULL
Changes	NULL
in	NULL
membrane	NULL
phospholipid	NULL
distribution	NULL
during	NULL
platelet	NULL
activation	NULL
.	NULL

Biochim	NULL
Bio-phys	NULL
Acta	NULL
736:57	NULL
,	NULL
1983	NULL
38	NULL
.	NULL

Casciola-Rosen	NULL
L	NULL
,	NULL
Rosen	NULL
A	NULL
,	NULL
Petri	NULL
M	NULL
,	NULL
Schlissel	NULL
M	NULL
:	NULL
Surface	NULL
blebs	NULL
on	NULL
apoptotic	NULL
cells	NULL
are	NULL
sites	NULL
of	NULL
enhanced	NULL
procoagulant	NULL
activity	NULL
:	NULL
Implications	NULL
for	NULL
coagulation	NULL
events	NULL
and	NULL
antigenic	NULL
spread	NULL
in	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:1624	NULL
,	NULL
1996	NULL
39	NULL
.	NULL

Taubman	NULL
MB	NULL
:	NULL
Tissue	NULL
factor	NULL
regulation	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
:	NULL
A	NULL
summary	NULL
of	NULL
studies	NULL
performed	NULL
using	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
models	NULL
.	NULL

Am	NULL
J	NULL
Cardiol	NULL
72:55C	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Wilcox	NULL
JN	NULL
,	NULL
Smith	NULL
KM	NULL
,	NULL
Schwartz	NULL
SM	NULL
,	NULL
Gordon	NULL
D	NULL
:	NULL
Localization	NULL
of	NULL
tissue	NULL
factor	NULL
in	NULL
the	NULL
normal	NULL
vessel	NULL
wall	NULL
and	NULL
in	NULL
the	NULL
atherosclerotic	NULL
plaque	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:2839	NULL
,	NULL
1989	NULL
41	NULL
.	NULL

Duguid	NULL
JB	NULL
:	NULL
Thrombosis	NULL
as	NULL
a	NULL
factor	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
coronary	NULL
atherosclerosis	NULL
.	NULL

J	NULL
Pathol	NULL
Bacteriol	NULL
58:207	NULL
,	NULL
1946	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1997	NULL
89	NULL
:	NULL
4378-4384	NULL
Thrombin	NULL
Generation	NULL
by	NULL
Apoptotic	NULL
Vascular	NULL
Smooth	NULL
Muscle	NULL
Cells	NULL
Paul	NULL
D.	NULL
Flynn	NULL
,	NULL
Christopher	NULL
D.	NULL
Byrne	NULL
,	NULL
Trevor	NULL
P.	NULL
Baglin	NULL
,	NULL
Peter	NULL
L.	NULL
Weissberg	NULL
and	NULL
Martin	NULL
R.	NULL
Bennett	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/89/12/4378.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hemostasis	NULL
,	NULL
Thrombosis	NULL
,	NULL
and	NULL
Vascular	NULL
Biology	NULL
(	NULL
2485	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

